<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Protein Cell</journal-id><journal-id journal-id-type="iso-abbrev">Protein Cell</journal-id><journal-title-group><journal-title>Protein &#x00026; Cell</journal-title></journal-title-group><issn pub-type="ppub">1674-800X</issn><issn pub-type="epub">1674-8018</issn><publisher><publisher-name>Higher Education Press</publisher-name><publisher-loc>Beijing</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7251012</article-id><article-id pub-id-type="publisher-id">722</article-id><article-id pub-id-type="doi">10.1007/s13238-020-00722-w</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Non-enzymatic covalent modifications: a new link between metabolism and epigenetics</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8397-3507</contrib-id><name><surname>Zheng</surname><given-names>Qingfei</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Maksimovic</surname><given-names>Igor</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Upad</surname><given-names>Akhil</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1696-0025</contrib-id><name><surname>David</surname><given-names>Yael</given-names></name><address><email>davidshy@mskcc.org</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.51462.34</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9952</institution-id><institution>Chemical Biology Program, </institution><institution>Memorial Sloan Kettering Cancer Center, </institution></institution-wrap>New York, NY 10065 USA </aff><aff id="Aff2"><label>2</label>Tri-Institutional PhD Program in Chemical Biology, New York, NY 10065 USA </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.5386.8</institution-id><institution-id institution-id-type="ISNI">000000041936877X</institution-id><institution>Department of Pharmacology, </institution><institution>Weill Cornell Medicine, </institution></institution-wrap>New York, NY 10065 USA </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.5386.8</institution-id><institution-id institution-id-type="ISNI">000000041936877X</institution-id><institution>Department of Physiology, Biophysics and Systems Biology, </institution><institution>Weill Cornell Medicine, </institution></institution-wrap>New York, NY 10065 USA </aff></contrib-group><pub-date pub-type="epub"><day>30</day><month>4</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>30</day><month>4</month><year>2020</year></pub-date><pub-date pub-type="ppub"><month>6</month><year>2020</year></pub-date><volume>11</volume><issue>6</issue><fpage>401</fpage><lpage>416</lpage><history><date date-type="received"><day>10</day><month>3</month><year>2020</year></date><date date-type="accepted"><day>2</day><month>4</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2020</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Epigenetic modifications, including those on DNA and histones, have been shown to regulate cellular metabolism by controlling expression of enzymes involved in the corresponding metabolic pathways. In turn, metabolic flux influences epigenetic regulation by affecting the biosynthetic balance of enzyme cofactors or donors for certain chromatin modifications. Recently, non-enzymatic covalent modifications (NECMs) by chemically reactive metabolites have been reported to manipulate chromatin architecture and gene transcription through multiple mechanisms. Here, we summarize these&#x000a0;recent advances in the identification and characterization of NECMs on nucleic acids, histones, and transcription factors, providing an additional mechanistic link between metabolism and epigenetics.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>epigenetics</kwd><kwd>metabolism</kwd><kwd>non-enzymatic modification</kwd><kwd>chromatin</kwd><kwd>human disease</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">The genetic information of eukaryotes and archaea is packaged in the nucleus as a dynamic nucleoprotein chromatin complex that not only stores it efficiently but also&#x000a0;allows it to remain readily accessible (Ammar et al., <xref ref-type="bibr" rid="CR2">2012</xref>). At the molecular level, the DNA strand wraps&#x000a0;approximately 1.65 times around a histone octamer complex, which itself consists of two copies of each of the four core histones (i.e., H2A, H2B, H3, and H4) forming a nucleosome, the fundamental unit of chromatin (McGinty and Tan, <xref ref-type="bibr" rid="CR58">2015</xref>). Histones contain an unusually high representation of positively charged lysine and arginine residues that electrostatically interact with the negatively charged phosphodiester backbone of DNA&#x000a0;and stabilize&#x000a0;the nucleosome core particle (Erler et al., <xref ref-type="bibr" rid="CR22">2014</xref>). To regulate the interactions between histones and nucleosomal DNA or transcription factors (TFs), the histone residue side-chains are modified, typically through enzyme-mediated incorporation of metabolite molecules or cofactors, such as acetylation and methylation, and even full proteins, such as ubiquitination and sumoylation (Bannister and Kouzarides, <xref ref-type="bibr" rid="CR4">2011</xref>). The resulting plethora of modifications regulate cellular physiology by directly impacting chromatin structure and the pattern of gene expression, including essential enzymes involved in metabolic pathways (Janke et al., <xref ref-type="bibr" rid="CR37">2015</xref>). Thereafter, these enzymes can directly influence the epigenetic state of DNA, RNA and histones by balancing the biosynthesis of co-factors that serve as the co-substrates and donors for covalent modifications (e.g., S-adenosyl methionine for methylation and acyl-coenzyme A for acylation), thereby propagating the feedback loop (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>) (Rinschen et al., <xref ref-type="bibr" rid="CR74">2019</xref>).<fig id="Fig1"><label>Figure&#x000a0;1</label><caption><p>The multi-level crosstalk&#x000a0;between metabolism and epigenetic regulation&#x000a0;of cellular&#x000a0;transcription</p></caption><graphic xlink:href="13238_2020_722_Fig1_HTML" id="MO1"/></fig></p><p id="Par3">Beyond enzyme-mediated epigenetic modifications, chemically reactive metabolites have been shown to directly modify nucleotides and histones via spontaneous non-enzymatic reactions (Zheng et al., <xref ref-type="bibr" rid="CR112">2019</xref>). Unlike canonical post-translational modifications (PTMs), non-enzymatic covalent modifications (NECMs) accumulate over time&#x000a0;and are much more dependent on the cellular microenvironment (Harmel and Fiedler, <xref ref-type="bibr" rid="CR34">2018</xref>). Although metabolite-induced NECMs have lower selectivity than enzymatic modifications, histone proteins are particularly susceptible to NECMs due to their long half-lives within cells and disordered, nucleophilic tails (Commerford et al., <xref ref-type="bibr" rid="CR11">1982</xref>). Indeed, NECMs have emerged as a new family of chromatin modifications with direct effect on its structure and function. These NECMs have been identified on DNA, RNA and histones and are implicated in disease states; however, their pathophysiological mechanisms, particularly, the presence of any causative relationships, remain elusive (Zheng et al., <xref ref-type="bibr" rid="CR112">2019</xref>). In this review, we summarize recent advances in NECM characterization, categorize them based on chemical reactions, and discuss their corresponding functions in disease progression, subsequently providing new perspectives regarding the link between&#x000a0;metabolism, diet, and epigenetic regulation.</p></sec><sec id="Sec2"><title>Glycation</title><p id="Par4">The Maillard reaction is well known in food chemistry, where aldehyde groups of reducing sugars, most of which are aldoses (glucose, ribose, deoxyribose, fucose, glyceraldehyde etc.), react non-enzymatically with the nucleophilic groups (e.g., amine, sulfydryl and hydroxyl) of biomacromolecules such as DNA, RNA and proteins, in a process known as&#x000a0;glycation (Hellwig and Henle, <xref ref-type="bibr" rid="CR35">2014</xref>). Unlike O-linked glycosylation which is&#x000a0;regulated by O-GlcNAc transferase and O-GlcNAcase, glycation donors do not require activation by uridine diphosphate (UDP) and their modification sites on proteins are primarily lysine residues instead of serine, threonine or tyrosine (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>A) (Spiro, <xref ref-type="bibr" rid="CR82">2002</xref>). The glycation process is relatively slow as once the initial Schiff base is formed (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>B), a rate-limiting isomerization step is required to drive the cascade forward (Hellwig and Henle, <xref ref-type="bibr" rid="CR35">2014</xref>). However, upon the completion of this hydride shift, an array of rearrangement products is rapidly generated, ultimately forming chemically stable advanced glycation end products (AGEs) (Singh et al., <xref ref-type="bibr" rid="CR81">2001</xref>).<fig id="Fig2"><label>Figure&#x000a0;2</label><caption><p><bold>Glycation and sugar-dependent protein PTMs</bold>. (A) O-GlcNAc transferase (OGT)-catalyzed protein glycosylation. (B) Glucose and fructose-mediated protein glycation. (C) Generation of MGO in cells and the glycation reactions induced by it. NECMs induced by dopegal (D) and isolevuglandin (E) via the Maillard chemistry</p></caption><graphic xlink:href="13238_2020_722_Fig2_HTML" id="MO2"/></fig></p><p id="Par5">Besides the canonical reducing monosaccharides that can be assimilated through nutrition, several sugar metabolism intermediates are also spawned from glycation pathways within cells. For instance, methylglyoxal (MGO; C<sub>3</sub>H<sub>4</sub>O<sub>2</sub>) is a reactive dicarbonyl sugar metabolite that spontaneously reacts with primary amine and guanidino groups (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>C) (Schalkwijk and Stehouwer, <xref ref-type="bibr" rid="CR77">2020</xref>). While MGO is primarily generated as a byproduct during glycolysis (Allaman et al., <xref ref-type="bibr" rid="CR1">2015</xref>), it can also be biosynthesized from aminoacetone by a semicarbazide-sensitive amine oxidase (SSAO) (Obata, <xref ref-type="bibr" rid="CR64">2006</xref>) or oxidized from acetone by a P450 enzyme, CYP2E1 (Bondoc et al., <xref ref-type="bibr" rid="CR8">1999</xref>) (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>C). MGO is enriched in metabolically dysfunctional cells that overly rely on glycolysis for energy, resulting in the buildup of the glycolytic intermediates glyceraldehyde-3-phosphate (GA3P) and dihydroxyacetone phosphate (DHAP), which ultimately fragment into MGO (Allaman et al., <xref ref-type="bibr" rid="CR1">2015</xref>). Other types of aldehyde-bearing metabolites (e.g., ascorbic acid, dopegal, formaldehyde, 5-formylcytosine, and isolevuglandins) also form NECMs on proteins via the same Maillard chemistry (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>D and <xref rid="Fig2" ref-type="fig">2</xref>E) (Linetsky et al., <xref ref-type="bibr" rid="CR50">2007</xref>; Szende and Tyih&#x000e1;k, <xref ref-type="bibr" rid="CR86">2010</xref>; May-Zhang et al., <xref ref-type="bibr" rid="CR57">2018</xref>; Raiber et al., <xref ref-type="bibr" rid="CR68">2018</xref>; Wanner et al., <xref ref-type="bibr" rid="CR100">2020</xref>).</p><sec id="Sec3"><title>DNA and RNA glycation</title><p id="Par6">Previous studies have demonstrated that guanine residues in DNA and RNA can undergo methylglyoxal glycation (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>A), thereby inducing DNA and RNA damage (Jaramillo et al., <xref ref-type="bibr" rid="CR38">2017</xref>; Shuck et al., <xref ref-type="bibr" rid="CR79">2018</xref>). The MGO-induced DNA damage product, N<sup>2</sup>-carboxyethyl-2&#x02019;-deoxyguanosine (CEdG) (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>A), is a significant DNA AGE in human cells (~1 in 107 dG) (Synold et al., <xref ref-type="bibr" rid="CR85">2008</xref>). CEdG has been reported to be mutagenic in human cells and contributes to genomic instability, while this DNA damage has few corresponding repair pathways (Wuenschell et al., <xref ref-type="bibr" rid="CR104">2010</xref>; Tamae et al., <xref ref-type="bibr" rid="CR90">2011</xref>). Based on its reactivity against RNA (Mitchell et al., <xref ref-type="bibr" rid="CR59">2018</xref>), MGO derivatives have been applied as RNA structural probes of guanine base-pairing for transcriptome-wide RNA structure mapping (Weng et al., <xref ref-type="bibr" rid="CR102">2020</xref>). Finally, MGO-induced DNA/RNA glycation might be an important biomarker in human diseases such as diabetes and cancer (Jaramillo et al., <xref ref-type="bibr" rid="CR38">2017</xref>), however, there remains a lack of efficient sequencing methods reported for global profiling of DNA/RNA glycation sites.<fig id="Fig3"><label>Figure&#x000a0;3</label><caption><p>Glycation of DNA/RNA (A), histones (B), transcription factors (C), and its corresponding consequences in epigenetic regulation</p></caption><graphic xlink:href="13238_2020_722_Fig3_HTML" id="MO3"/></fig></p></sec><sec id="Sec4"><title>Histone glycation</title><p id="Par7">Histones are primary glycation substrates because of their long half-lives and abundant lysine (Lys) and arginine (Arg) residues (Zheng et al., <xref ref-type="bibr" rid="CR113">2019</xref>). While different types of aldose-induced histone glycation have been observed through both <italic>in vitro</italic> and <italic>in vivo</italic> experiments for decades (Talasz et al., <xref ref-type="bibr" rid="CR89">2002</xref>), an epigenetic link and working model in disease states has only been recently reported (Zheng et al., <xref ref-type="bibr" rid="CR113">2019</xref>). Specifically, histone glycation was found to induce epigenetic dysregulation through three distinct mechanisms: 1) competition with essential enzymatic PTMs for sites (e.g., glycation adducts replace H3K4me3 and H3R8me2), 2) changing the charge states of histone tails and subsequently affecting the compaction state of the fiber, and 3) altering three-dimensional chromatin architecture by inducing both histone-histone and histone-DNA crosslinking (Zheng et al., <xref ref-type="bibr" rid="CR113">2019</xref>). The epigenetic impacts of histone glycation were shown to be dependent on sugar concentration and exposure time. These results were summarized in a two-stage histone MGO-glycation damage model, which proposed that the initial acute exposure stage introduces a low number of scattered&#x000a0;adducts induces chromatin 'relaxation',&#x000a0;transitions to fiber compaction following chronic exposure due to AGE and cross-link formation (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>B) (Zheng et al., <xref ref-type="bibr" rid="CR113">2019</xref>). The two-stage model intuitively suggests that histone glycation serves as a double-edged sword in gene transcription, where the compaction of chromatin is dynamically manipulated first by spontaneous rearrangement and then by crosslinking of glycation products. Despite their well-documented occurrence and effects, the detailed structures of histone AGEs are still poorly understood because of their highly dynamic nature, chemical complexity and low abundance. The most prominently used methods for characterization of histone glycation are mass spectrometry and antibody-based immunological assays (Galligan et al., <xref ref-type="bibr" rid="CR27">2018</xref>). However, new chemical tools (Zheng et al., <xref ref-type="bibr" rid="CR115">2020</xref>) and proteomics methods (Chen et al., <xref ref-type="bibr" rid="CR10">2019</xref>), capable of tracking or discerning specific adducts, are currently being developed to further understand the biochemical mechanisms of these events.</p></sec><sec id="Sec5"><title>Transcription factor glycation</title><p id="Par8">The oncoprotein, nuclear factor erythroid 2-related factor 2 (NRF2), is a master regulator of the antioxidant response pathway and serves as a key pathological transcription factor in diseases such as cancer and atherosclerosis (Kawai et al., <xref ref-type="bibr" rid="CR43">2011</xref>). NRF2 exercises its functions in association with Kelch ECH associating protein 1 (KEAP1), in what is designated the KEAP1-NRF2 pathway (Kansanen et al., <xref ref-type="bibr" rid="CR42">2013</xref>). KEAP1 is a substrate adaptor protein for a CUL3-dependent E3 ubiquitin ligase complex which targets NRF2 for ubiquitination and subsequent degradation by the 26S proteasome (Zhang et al., <xref ref-type="bibr" rid="CR109">2004</xref>). PTMs on KEAP1, as well as oxidative and electrophilic stress, can reduce its ubiquitination activity, resulting in the cellular accumulation and activation of NRF2 (Keum, <xref ref-type="bibr" rid="CR44">2011</xref>; Kansanen et al., <xref ref-type="bibr" rid="CR42">2013</xref>). This in turn initiates the transcription of cytoprotective genes at antioxidant-response element loci.</p><p id="Par9">Two recent studies demonstrated that both KEAP1 (Bollong et al., <xref ref-type="bibr" rid="CR7">2018</xref>) and NRF2 (Sanghvi et al., <xref ref-type="bibr" rid="CR76">2019</xref>) undergo glycation under physiologically relevant metabolic stress. The glycation of multiple lysine residues of NRF2 inhibits its oncogenic function, which is reversed by the deglycase activity of fructosamine-3-kinase (FN3K, Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>C) (Sanghvi et al., <xref ref-type="bibr" rid="CR76">2019</xref>). Moreover, MGO selectively modifies KEAP1 to form a methylimidazole crosslink between proximal cysteine and arginine residues, resulting in the covalent dimerization of KEAP1 as well as the accumulation of NRF2 once more (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>C) (Bollong et al., <xref ref-type="bibr" rid="CR7">2018</xref>). These findings illustrate that sugar molecules can influence epigenetic events through glycation of transcription factors and/or their associated regulatory proteins.</p></sec><sec id="Sec6"><title>Regulatory mechanisms of glycation</title><p id="Par10">Since excessive glycation forms crosslinks within chromatin, which blocks transcription, distinct pathways have evolved to ameliorate cellular glycation damage (Zheng et al., <xref ref-type="bibr" rid="CR112">2019</xref>). These regulatory mechanisms include preventing the initial glycation by scavenging the free reducing sugar molecules as well as directly deglycating the modified substrates. In mammalian cells, scavenger systems systematically remove most of dicarbonyl molecules while deglycases such as FN3K (Szwergold et al., <xref ref-type="bibr" rid="CR87">2001</xref>), PAD4 (Zheng et al., <xref ref-type="bibr" rid="CR114">2019</xref>), and DJ-1 (Lee et al., <xref ref-type="bibr" rid="CR47">2012</xref>; Richarme et al., <xref ref-type="bibr" rid="CR72">2015</xref>; Richarme et al., <xref ref-type="bibr" rid="CR73">2017</xref>) are tasked with detecting and reversing the remainder.</p><p id="Par11">In addition,&#x000a0;Glyoxalases 1 (GLO1) and 2 (GLO2) together form a GLO1/GLO2 pathway that converts free MGO to D-lactate using glutathione (GSH) as a cofactor (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>A) (Xu and Chen, <xref ref-type="bibr" rid="CR105">2006</xref>; Distler and Palmer, <xref ref-type="bibr" rid="CR17">2012</xref>). First, the glutathione reacts with the dicarbonyl and forms a hemithioacetal which GLO1 can convert into lactoyl-glutathione (Distler and Palmer, <xref ref-type="bibr" rid="CR17">2012</xref>). GLO2 then hydrolyzes the lactoyl-glutathione, releasing D-lactate and regenerating the glutathione (Xu and Chen, <xref ref-type="bibr" rid="CR105">2006</xref>). Carnosine synthase 1 (CARNS1) is an ATP-dependent enzyme that catalyzes the condensation of L-histidine and &#x003b2;-alanine to form the dipeptide metabolite carnosine (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>B) (Drozak et al., <xref ref-type="bibr" rid="CR20">2010</xref>). Carnosine is an endogenous small molecule scavenger for both reactive oxygen species (ROS) and reactive carbonyl species (RCS) (Cripps et al., <xref ref-type="bibr" rid="CR12">2017</xref>). These scavenging mechanisms inspired the development of drug leads, such as alagebrium chloride (ALT-711), for anti-glycation and anti-aging (Little et al., <xref ref-type="bibr" rid="CR51">2005</xref>).<fig id="Fig4"><label>Figure&#x000a0;4</label><caption><p>Biochemical mechanisms for antagonizing glycation by GLO1/GLO2 (A), CARNS (B), FN3K (C), DJ-1 (D), and MnmC (E)</p></caption><graphic xlink:href="13238_2020_722_Fig4_HTML" id="MO4"/></fig></p><p id="Par12">As a kinase, FN3K catalyzes the C-3 phosphorylation of fructosamines formed by glucose-glycation, and the resulting unstable phosphate product undergoes spontaneous cleavage to yield 3-deoxyglucosone (3DG) and the regenerated amine (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>C) (Van Schaftingen et al., <xref ref-type="bibr" rid="CR96">2007</xref>). This enzymatic activity of FN3K has been demonstrated through both <italic>in vitro</italic> and <italic>in vivo</italic> experiments, however, its mitochondrial and cytosolic subcellular localization restricts FN3K from exhibiting its deglycation function as an eraser enzyme in the nucleus (Veiga da-Cunha et al., <xref ref-type="bibr" rid="CR97">2006</xref>). Alternatively, peptidyl arginine deiminase 4 (PAD4/PADI4) is known to be responsible for the conversion of arginine side-chains into citrulline (Suzuki et al., <xref ref-type="bibr" rid="CR84">2002</xref>) and antagonizing histone arginine methylation (Cuthbert et al., <xref ref-type="bibr" rid="CR15">2004</xref>; Wang et al., <xref ref-type="bibr" rid="CR99">2004</xref>). Recently, PAD4 has been shown to be capable of reversing MGO-glycation on H3 and H4 and converting their early glycated arginine adducts into citrulline (Zheng et al., <xref ref-type="bibr" rid="CR114">2019</xref>). DJ-1 (also referred to as PARK7) belongs to the peptidase C56 family of proteins and protects neurons against oxidative stress and cell death (Taira et al., <xref ref-type="bibr" rid="CR88">2004</xref>). Its catalytic cysteine residue (C106) is positioned in a &#x02018;nucleophilic elbow&#x02019; and responsible for both its oxidative stress sensing and deglycase activity (Nair et al., <xref ref-type="bibr" rid="CR62">2018</xref>). Previous studies indicate that DJ-1 erases early glyoxal (GO) and MGO-glycation adducts from both nucleotides and proteins (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>D) (Richarme and Dairou, <xref ref-type="bibr" rid="CR71">2017</xref>). Moreover, DJ-1 is also capable of converting free MGO into L/D-lactate through intermolecular hydrolysis of DJ-1 arginine and lysine residues that have reacted with the free MGO and formed early glycation intermediates (Toyoda et al., <xref ref-type="bibr" rid="CR92">2014</xref>; Zheng et al., <xref ref-type="bibr" rid="CR113">2019</xref>). Intriguingly, MnmC, which is involved in the bacterial tRNA-modification pathway and is FAD-dependent, was recently reported to be capable of reversing the AGEs, carboxyethyl-lysine (CEL) and carboxymethyl-lysine (CML), releasing an unmodified lysine structure (Kim et al., <xref ref-type="bibr" rid="CR45">2019</xref>). The engineered variant of MnmC has improved catalytic properties against CEL (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>E), thus providing insights into future protein-based therapies for AGE-induced protein damage (Kim et al., <xref ref-type="bibr" rid="CR45">2019</xref>).</p></sec><sec id="Sec7"><title>Glycation and human diseases</title><p id="Par13">Metabolic syndromes and diabetes increase the risks associated with neurodegenerative diseases, cancer, and hypoimmunity, among other disorders (Kopelman, <xref ref-type="bibr" rid="CR46">2007</xref>). Aldose-induced glycation opens a new door to expound this clinical phenomenon, however, an accurate mechanistic explanation for the correlation between glycation and human disease has remained elusive. Existing efforts indicate that glycation plays important pathophysiological roles in disease progression (Fournet et al., <xref ref-type="bibr" rid="CR24">2018</xref>). In cancer, imbalanced glycation could promote cancer by&#x000a0;several mechniasms; the two recent transcription factor studies uncovered completely distinct biological implications of the NRF2/KEAP1 glycation pathway in cancer development. The glucose-induced glycation of NRF2 influences its protein-protein interaction properties and suppresses its oncogenic activity (Sanghvi et al., <xref ref-type="bibr" rid="CR76">2019</xref>), while the MGO-induced glycation of the tumor suppressor KEAP1 causes&#x000a0;the accumulation of NRF2 in cells and thus promotes cancer progression (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>C) (Bollong et al., <xref ref-type="bibr" rid="CR7">2018</xref>). The two-stage model of histone MGO-glycation (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>B) also provides a practical explanation for the observation that moderate amounts of MGO benefits cancer cell proliferation through the promotion of promiscuous transcription, while excess MGO causes chromatin crosslinking, subsequently abated transcription, and ultimately leads to cell death (Zheng et al., <xref ref-type="bibr" rid="CR113">2019</xref>).</p><p id="Par14">In neurons, MGO-glycation of Nav1.8, a human sodium ion channel, intensifies nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy (Bierhaus et al., <xref ref-type="bibr" rid="CR6">2012</xref>). Furthermore, for decades, AGEs have been correlated to neurodegenerative disorders such as Alzheimer&#x02019;s, Parkinson&#x02019;s, and Huntington&#x02019;s diseases (Li et al., <xref ref-type="bibr" rid="CR48">2012</xref>). Interestingly, the deglycase activity of DJ-1, which is also known as Parkinson disease protein 7 (PARK7), plays an important role in the progression of a familial form of Parkinson&#x02019;s disease (Repici and Giorgini, <xref ref-type="bibr" rid="CR70">2019</xref>). Given that core histones in neurons have extremely long half-lives due to lack in replication, one hypothesis proposes that DJ-1&#x02019;s deglycase activity is a protection mechanism against the development of neurodegenerative diseases (Ariga et al., <xref ref-type="bibr" rid="CR3">2013</xref>).</p><p id="Par15">It has been well established that diabetic patients experience significant and characteristic hypoimmunity and/or immune dysfunction (Geerlings and Hoepelman, <xref ref-type="bibr" rid="CR29">1999</xref>). Previous studies also showed that high plasma concentrations of aldoses or reactive carbonyls, such as methylglyoxal, are associated with obesity and diabetes (Matafome et al., <xref ref-type="bibr" rid="CR54">2013</xref>). One possible mechanism for the formation of diabetic hypoimmunity is that aldose-mediated glycation of immunoglobulins and surface receptors causes immunocyte exhaustion, while histone and DNA glycation may lead to long term epigenetic impacts on immune responses (Wei et al., <xref ref-type="bibr" rid="CR101">2017</xref>; Teodorowicz et al., <xref ref-type="bibr" rid="CR91">2018</xref>).</p></sec></sec><sec id="Sec8"><title>Acylation</title><p id="Par16">Acylation is a ubiquitous and important post-translational modification that regulates&#x000a0;protein structure and function (Drazic et al., <xref ref-type="bibr" rid="CR19">2016</xref>). While most of the cellular protein acylations are facilitated by acyltransferases, non-enzymatic acylation induced by activated esters or anhydrides is also widely reported (Wagner and Hirschey, <xref ref-type="bibr" rid="CR98">2014</xref>). Importantly, some of these non-enzymatic acylation adducts were shown to be removed by common deacylases such as SIRT2 and SIRT3 (Wagner and Hirschey, <xref ref-type="bibr" rid="CR98">2014</xref>). Since most of the reported deacylases (such as the sirtuin family) are cofactor NAD<sup>+</sup>-dependent, the metabolic disorder of NAD<sup>+</sup> and NADH biosynthesis will also influence the deacetylation regulations in cells (Wagner and Hirschey, <xref ref-type="bibr" rid="CR98">2014</xref>; Drazic et al., <xref ref-type="bibr" rid="CR19">2016</xref>).</p><p id="Par17">Coenzyme A-activated thioesters of different acids not only serve as donors for enzymatic acylation but also non-enzymatically modify proteins, generating acylated lysine residues (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>A). Recently, the GSH-activated thioester of lactate has been reported to serve as the donor for lysine lactoylation of glycolytic enzymes (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>B) (Gaffney et al., <xref ref-type="bibr" rid="CR25">2019</xref>) while CoA-activated lactate serves a similar function on histones (Zhang et al., <xref ref-type="bibr" rid="CR111">2019</xref>). The lactoylation donor, lactoyl-glutathione, can be specifically hydrolyzed by GLO2 and DJ-1 (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>B) (Xu and Chen, <xref ref-type="bibr" rid="CR105">2006</xref>; Matsuda et al., <xref ref-type="bibr" rid="CR56">2017</xref>). Interestingly, since GSH-activated lactate is biosynthesized by GLO1 from MGO (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>A) (Distler and Palmer, <xref ref-type="bibr" rid="CR17">2012</xref>), lactoylation is a new type of NECM indirectly induced by MGO. Homocysteine thiolactone (HTL) is an intramolecular thioester of homocysteine (Hcy), which induces non-enzymatic homocysteinylation on lysine residues (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>C) (Jakubowski, <xref ref-type="bibr" rid="CR36">2000</xref>). Recent studies in neuronal tissues have shown that multiple residues of all four core histones can be modified by HTL, subsequently down-regulating the expression of selected neuronal-tube closure-related genes (Xu et al., <xref ref-type="bibr" rid="CR107">2015</xref>; Zhang et al., <xref ref-type="bibr" rid="CR110">2018</xref>). This discovery provides a potential mechanistic explanation for the correlation between high maternal Hcy levels and developmental neuronal tube defects.<fig id="Fig5"><label>Figure&#x000a0;5</label><caption><p>Non-enzymatic acylation induced by acyl-CoA (A), lactoyl-glutathione (B), HTL (C), 3&#x02019;-formyl phosphate (D), and 1,3-BPG (E)</p></caption><graphic xlink:href="13238_2020_722_Fig5_HTML" id="MO5"/></fig></p><p id="Par18">Anhydrides are more active than esters, making them even better donors for non-enzymatic acylation. An anhydride generated during DNA damage, 3&#x02019;-formyl phosphate, serves as an acyl donor for lysine formylation (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>D) (Jiang et al., <xref ref-type="bibr" rid="CR41">2007</xref>). An additional anhydride, 1,3-bisphosphoglycerate (1,3-BPG), is a primary glycolytic intermediate that selectively reacts with lysine residues forming 3-phosphoglyceryl-lysine (pgK, Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>E) (Moellering and Cravatt, <xref ref-type="bibr" rid="CR60">2013</xref>). Interestingly, pgK modifications have been demonstrated to inhibit glycolytic enzymes and accumulate on proteins generating a potential feedback mechanism for glycolysis regulation (Moellering and Cravatt, <xref ref-type="bibr" rid="CR60">2013</xref>).</p></sec><sec id="Sec9"><title>Alkylation</title><p id="Par19">Alkylation of proteins or nucleosides is usually induced by alkylating agents ingested from the environment, such as methylnitrosourea (MNU) and tobacco-specific nitrosamines (Shuker et al., <xref ref-type="bibr" rid="CR80">1993</xref>). However, the non-enzymatic alkylations induced by endogenous metabolites (e.g., S-adenosyl-L-methionine) have been reported to be potentially mutagenic reactions (Rydberg and Lindahl, <xref ref-type="bibr" rid="CR75">1982</xref>). Compounds with ring strain, such as the microbial metabolite, yatakemycin, which contains a unique chiral cyclopropane moiety, also exhibit alkylating activities (Parrish et al., <xref ref-type="bibr" rid="CR66">2003</xref>). Yatakemycin is a DNA-alkylating agent with remarkable cytotoxicity against cancer cells, and its resulting alkylation adducts can be&#x000a0;removed by the DNA glycosylase, YtkR2 (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>A) (Xu et al., <xref ref-type="bibr" rid="CR106">2012</xref>). Another alkylating agent, colibactin (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>B), is a genotoxic secondary metabolite produced by microorganisms harboring the <italic>pks</italic> genomic island, including certain gut commensal <italic>Escherichia coli</italic> strains (<italic>pks</italic><sup><italic>+</italic></sup><italic>E</italic>. <italic>coli</italic>). Alkylation by colibactin causes multiple epigenetic impacts on the host organisms, including cell cycle arrest, DNA double-strand breaks, and senescence (Wilson et al., <xref ref-type="bibr" rid="CR103">2019</xref>). Moreover, colibactin-producing <italic>E</italic>. <italic>coli</italic> have been shown to accelerate colorectal cancer tumor progression, a finding that defined a new link between gut microbiota and human disease (Dalmasso et al., <xref ref-type="bibr" rid="CR16">2014</xref>).<fig id="Fig6"><label>Figure&#x000a0;6</label><caption><p>Non-enzymatic alkylation induced by microbial metabolites, yatakemycin (A) and colibactin (B)</p></caption><graphic xlink:href="13238_2020_722_Fig6_HTML" id="MO6"/></fig></p></sec><sec id="Sec10"><title>Michael addition</title><p id="Par20">Enones, also termed &#x003b1;, &#x003b2;-unsaturated carbonyls, are reactive electrophilic agents that can non-enzymatically modify nucleophilic groups of proteins and nucleosides (e.g., -SH, -NH<sub>2</sub> and -OH) via the Michael addition. The oxidation of cellular lipids generate &#x003b1;, &#x003b2;-unsaturated alkenals, including 4-hydroxy-2-nonenal (4-HNE) and 4-oxo-2-nonenal (4-ONE) (Doorn and Petersen, <xref ref-type="bibr" rid="CR18">2002</xref>; N&#x000e4;sstr&#x000f6;m et al., <xref ref-type="bibr" rid="CR63">2011</xref>). These electrophilic metabolites form adducts on both DNA and histone proteins, altering the structures and functions of chromatin (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>) (Sun et al., <xref ref-type="bibr" rid="CR83">2017</xref>). The 4-ONE non-enzymatic addition to histones H3 and H4 was reported to prevent nucleosome assembly and occupy histone PTM sites that are essential for epigenetic regulations (e.g., H3K23 and H3K27) (Galligan et al., <xref ref-type="bibr" rid="CR26">2014</xref>). Similar to some acylations, the 4-ONE histone NECMs can be hydrolyzed by the deacylase, SIRT2 (Cui et al., <xref ref-type="bibr" rid="CR14">2017</xref>). These results suggest a connection between metabolic disorders, oxidative stress, and epigenetic regulation.<fig id="Fig7"><label>Figure&#x000a0;7</label><caption><p>NECMs induced by 4-HNE (A) and 4-ONE (B) via the Michael addition</p></caption><graphic xlink:href="13238_2020_722_Fig7_HTML" id="MO7"/></fig></p></sec><sec id="Sec11"><title>Redox reaction</title><p id="Par21">Redox reactions are some of the most important and ubiquitous chemical processes in all organisms (Ochs, <xref ref-type="bibr" rid="CR65">2019</xref>). Reactive oxygen species (ROS), such as H<sub>2</sub>O<sub>2</sub>, are continuously produced and scavenged in cells, and can oxidize cysteine thiols into sulfenic, sulfinic, or sulfonic acid (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref>A) (Chauvin and Pratt, <xref ref-type="bibr" rid="CR9">2017</xref>). These oxidations may often induce alterations in the structure and functions of proteins, which often act as sensors to induce a downstream cellular response to the oxidative state changes (Marinho et al., <xref ref-type="bibr" rid="CR53">2014</xref>). Although the precise pathological roles of ROS remain controversial (Schumacker, <xref ref-type="bibr" rid="CR78">2006</xref>), in human cells there are multiple oxidative stress sensor proteins including GAPDH and DJ-1, which have key regulatory cysteines sensitive to ROS fluctuations (Duan et al., <xref ref-type="bibr" rid="CR21">2008</xref>). Cells have evolved multiple mechanisms to complete the redox cycles, such as sulfiredoxin (SRX), a reported sulfinic acid reductase that can reduce cysteine sulfinylation (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref>A) (Basu and Koonin, <xref ref-type="bibr" rid="CR5">2005</xref>). Moreover, cells produce metabolites possessing thiol groups to reduce ROS and protect cellular components from oxidative damage (Poole, <xref ref-type="bibr" rid="CR67">2015</xref>). This class of reducing agents includes among others, GSH, ergothioneine (EGT) and mycothiol (MSH), which all play critical roles in the distinct domains of life (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref>B) (Hand and Honek, <xref ref-type="bibr" rid="CR33">2005</xref>; Van Laer et al., <xref ref-type="bibr" rid="CR95">2013</xref>). Intriguingly, some of these small-molecule thiols are reported to non-enzymatically modify protein cysteine residues via reduction, and this modification can be enzymatically reversed by deglutathionylase enzymes such as glutaredoxin (GRX) and thioredoxin (TRX) (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref>C) (Greetham et al., <xref ref-type="bibr" rid="CR30">2010</xref>). For example, H3 cysteines were shown to be modified by GSH through S-glutathionylation, which leads to a looser chromatin structure (Garc&#x000ed;a-Gim&#x000e9;nez et al., <xref ref-type="bibr" rid="CR28">2013</xref>). Importantly, the levels of S-glutathionylation increase during cellular proliferation and decrease during aging, highlighting a potential physiological causal relationship between non-enzymatic redox reactions and human health (Hake and Allis, <xref ref-type="bibr" rid="CR32">2006</xref>).<fig id="Fig8"><label>Figure&#x000a0;8</label><caption><p><bold>Non-enzymatic redox reactions</bold>. (A) Different oxidation states of cysteine side-chain. (B) Representative thiol-containing redox metabolites. (C) Glutathione oxidation of protein cysteine side-chain</p></caption><graphic xlink:href="13238_2020_722_Fig8_HTML" id="MO8"/></fig></p></sec><sec id="Sec12"><title>Conclusions and perspectives</title><p id="Par22">While NECMs are long-established in biochemistry, emergent questions surrounding aberrant metabolism-related human diseases have revitalized renewed interest in them. Although membrane proteins are the primary targets of serum metabolites (Matsuda et al., <xref ref-type="bibr" rid="CR55">2013</xref>), core histones are the principal targets of intracellular metabolites during NECM formation (Zheng et al., <xref ref-type="bibr" rid="CR112">2019</xref>). Because of their long half-lives and nucleophilic N-terminal tails, histones accumulate stable enzymatic and non-enzymatic PTMs. DNA and histone NECMs, spontaneously induced by multiple classes of reactive metabolites including ROS and RCS, providing a direct causal link between metabolism and long-term epigenetic dysregulation. We propose that histones adopt the roles of &#x02018;NECM sponges&#x02019; in cells as part of an epigenetic feedback loop in metabolic disorders.</p><p id="Par23">Incidentally, some of the NECM-inducing reactive metabolites are exogenous to human cells. Metabolites produced by human gastrointestinal microbiota are known to exhibit essential functions in quorum sensing and virulence (Li et al., <xref ref-type="bibr" rid="CR49">2018</xref>). However, a substantial body of evidence has shown that the reactive microbial metabolites, such as colibactin (Dalmasso et al., <xref ref-type="bibr" rid="CR16">2014</xref>) and peptide aldehydes (Guo et al., <xref ref-type="bibr" rid="CR31">2017</xref>), directly modify host DNA or proteins to influence the cell cycle and immune response. The studies of reactive metabolite-induced NECMs will continue to aid in understanding pathophysiological host-microbe interactions such as the gut-brain axis (Cryan et al., <xref ref-type="bibr" rid="CR13">2019</xref>).</p><p id="Par24">Relative to canonical and enzymatically regulated biomolecule modifications, NECMs are less characterized due to the structural diversity, dynamic nature, and instability of the adducts formed (Zhu et al., <xref ref-type="bibr" rid="CR116">2018</xref>). There is a critical need for novel approaches to study NECMs including the development of high-resolution trace mass spectrometry, chemical probes for specific enrichment, and site-specific antibodies. Individual and customized NECMs can also be specifically introduced into designated targets <italic>in vivo</italic> using intein-mediated protein splicing (Maksimovic et al., <xref ref-type="bibr" rid="CR52">2019</xref>) and amber codon suppression (Zhang et al., <xref ref-type="bibr" rid="CR108">2003</xref>).</p><p id="Par25">Overall, non-enzymatic covalent modifications, which are identified as a ubiquitous biomarker on biomacromolecules, have extended the so-called &#x02018;histone code&#x02019; (Jenuwein and Allis, <xref ref-type="bibr" rid="CR40">2001</xref>) and become a new link between metabolic disorders and epigenetic dysregulation. However, because epigenetic changes are heritable (Trerotola et al., <xref ref-type="bibr" rid="CR93">2015</xref>), cellular microenvironment-driven DNA and histone NECMs have potential implications in far-reaching processes such as embryonic development, ultimately resulting in postnatal impacts on organisms (Jawahar et al., <xref ref-type="bibr" rid="CR39">2015</xref>). Even though the interplay between metabolism and epigenetics has been well established in the past few years (Etchegaray and Mostoslavsky, <xref ref-type="bibr" rid="CR23">2016</xref>; Reid et al., <xref ref-type="bibr" rid="CR69">2017</xref>; Tzika et al., <xref ref-type="bibr" rid="CR94">2018</xref>; Montellier and Gaucher, <xref ref-type="bibr" rid="CR61">2019</xref>), recent studies of metabolite-induced epigenetic modifications opened a new door for understanding the missing links between them. Moreover, NECMs that target non-epigenetic proteins may also induce long-term biological effects and require further studies.</p></sec></body><back><ack><title>Acknowledgements</title><p>Work in the David lab is supported by R21 DA044767, CCSG core grant P30 CA008748, and SPORE P50-CA192937 from the National Institutes of Health. In addition, work in the lab is supported by the Tri-institutional Therapeutic Discovery Institute, the Mr. William H. Goodwin and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research and the Center for Experimental Therapeutics at MSKCC, the Pershing Square Sohn Cancer Research Alliance, and Cycle for Survival. Y.D. is a Josie Robertson Young Investigator. Additionally, YD is supported by the Parker Institute for Cancer Immunotherapy and the Anna Fuller Cancer Research Foundation.</p><sec id="FPar1"><title>Abbreviations</title><p id="Par26">AGE, advanced glycation end product; Arg, arginine; 1,3-BPG, 1,3-bisphosphoglycerate; CARNS1, carnosine synthase 1; CEdG, N<sup>2</sup>-carboxyethyl-2&#x02019;-deoxyguanosine; CEL, carboxyethyl-lysine; CML, carboxymethyl-lysine; Co-A, coenzyme A; CUL3, cullin 3; CYP2E1, cytochrome P450 family 2 subfamily E member 1; 3DG, 3-deoxyglucosone; DHAP, dihydroxyacetone phosphate; DNA, deoxyribonucleic acid; <italic>E</italic>. <italic>coli</italic>, <italic>Escherichia coli</italic>; EGT, ergothioneine; FN3K, fructosamine 3 kinas; GA3P, glyceraldehyde-3-phosphate; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; GlcNAc, N-acetylglucosamine; GLO, glyoxalases; GO, glyoxal; GRX, glutaredoxin; GSH, glutathione; Hcy, homocysteine; 4-HNE, 4-hydroxy-2-nonenal; HTL, homocysteine thiolactone; KEAP1, Kelch ECH associating protein 1; Lys, lysine; MGO, methylglyoxal; MNU, methylnitrosourea; MSH, mycothiol; NAD, nicotinamide adenine dinucleotide; NECM, non-enzymatic covalent modification; NRF2, nuclear factor erythroid 2-related factor; OGT, O-GlcNAc transferase; 4-ONE, 4-oxo-2-nonenal; PAD4, protein arginine deiminase 4; PARK7, Parkinson disease protein 7; pgK, 3-phosphoglyceryl-lysine; PTM, post-translational modification; RCS, reactive carbonyl species; RNA, ribonucleic acid; ROS, reactive oxygen species; SAM, S-adenosyl methionine; SIRT, sirtuin; SRX, sulfiredoxin; SSAO, semicarbazide-sensitive amine oxidase; TF, transcription factor; TRX, thioredoxin; UDP, uridine diphosphate</p></sec><sec id="FPar2"><title>Compliance with ethics guidelines</title><p id="Par27">All the authors of this paper declare that they have no conflict of interest. This article does not contain any studies with human or animal subjects performed by the any of the authors.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allaman</surname><given-names>I</given-names></name><name><surname>B&#x000e9;langer</surname><given-names>M</given-names></name><name><surname>Magistretti</surname><given-names>PJ</given-names></name></person-group><article-title>Methylglyoxal, the dark side of glycolysis</article-title><source>Front Neurosci</source><year>2015</year><volume>9</volume><fpage>23</fpage><?supplied-pmid 25709564?><pub-id pub-id-type="pmid">25709564</pub-id></element-citation></ref><ref id="CR2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ammar</surname><given-names>R</given-names></name><name><surname>Torti</surname><given-names>D</given-names></name><name><surname>Tsui</surname><given-names>K</given-names></name><name><surname>Gebbia</surname><given-names>M</given-names></name><name><surname>Durbic</surname><given-names>T</given-names></name><name><surname>Bader</surname><given-names>GD</given-names></name><name><surname>Giaever</surname><given-names>G</given-names></name><name><surname>Nislow</surname><given-names>C</given-names></name></person-group><article-title>Chromatin is an ancient innovation conserved between Archaea and Eukarya.</article-title><source>Elife</source><year>2012</year><volume>1</volume><fpage>e00078</fpage><?supplied-pmid 23240084?><pub-id pub-id-type="pmid">23240084</pub-id></element-citation></ref><ref id="CR3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ariga</surname><given-names>H</given-names></name><name><surname>Takahashi-Niki</surname><given-names>K</given-names></name><name><surname>Kato</surname><given-names>I</given-names></name><name><surname>Maita</surname><given-names>H</given-names></name><name><surname>Niki</surname><given-names>T</given-names></name><name><surname>Iguchi-Ariga</surname><given-names>SM</given-names></name></person-group><article-title>Neuroprotective function of DJ-1 in Parkinson&#x02019;s disease</article-title><source>Oxid Med Cell Longev</source><year>2013</year><volume>2013</volume><fpage>683920</fpage><?supplied-pmid 23766857?><pub-id pub-id-type="pmid">23766857</pub-id></element-citation></ref><ref id="CR4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bannister</surname><given-names>AJ</given-names></name><name><surname>Kouzarides</surname><given-names>T</given-names></name></person-group><article-title>Regulation of chromatin by histone modifications</article-title><source>Cell Res</source><year>2011</year><volume>21</volume><fpage>381</fpage><lpage>395</lpage><?supplied-pmid 3193420?><pub-id pub-id-type="pmid">21321607</pub-id></element-citation></ref><ref id="CR5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basu</surname><given-names>MK</given-names></name><name><surname>Koonin</surname><given-names>EV</given-names></name></person-group><article-title>Evolution of eukaryotic cysteine sulfinic acid reductase, sulfiredoxin (Srx), from bacterial chromosome partitioning protein ParB</article-title><source>Cell Cycle</source><year>2005</year><volume>4</volume><fpage>947</fpage><lpage>952</lpage><?supplied-pmid 15917647?><pub-id pub-id-type="pmid">15917647</pub-id></element-citation></ref><ref id="CR6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bierhaus</surname><given-names>A</given-names></name><name><surname>Fleming</surname><given-names>T</given-names></name><name><surname>Stoyanov</surname><given-names>S</given-names></name><name><surname>Leffler</surname><given-names>A</given-names></name><name><surname>Babes</surname><given-names>A</given-names></name><name><surname>Neacsu</surname><given-names>C</given-names></name><name><surname>Sauer</surname><given-names>SK</given-names></name><name><surname>Eberhardt</surname><given-names>M</given-names></name><name><surname>Schn&#x000f6;lzer</surname><given-names>M</given-names></name><name><surname>Lasitschka</surname><given-names>F</given-names></name><etal/></person-group><article-title>Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy</article-title><source>Nat Med</source><year>2012</year><volume>18</volume><fpage>926</fpage><lpage>933</lpage><?supplied-pmid 22581285?><pub-id pub-id-type="pmid">22581285</pub-id></element-citation></ref><ref id="CR7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bollong</surname><given-names>MJ</given-names></name><name><surname>Lee</surname><given-names>G</given-names></name><name><surname>Coukos</surname><given-names>JS</given-names></name><name><surname>Yun</surname><given-names>H</given-names></name><name><surname>Zambaldo</surname><given-names>C</given-names></name><name><surname>Chang</surname><given-names>JW</given-names></name><name><surname>Chin</surname><given-names>EN</given-names></name><name><surname>Ahmad</surname><given-names>I</given-names></name><name><surname>Chatterjee</surname><given-names>AK</given-names></name><name><surname>Lairson</surname><given-names>LL</given-names></name><etal/></person-group><article-title>A metabolite-derived protein modification integrates glycolysis with KEAP1-NRF2 signalling</article-title><source>Nature</source><year>2018</year><volume>562</volume><fpage>600</fpage><lpage>604</lpage><?supplied-pmid 30323285?><pub-id pub-id-type="pmid">30323285</pub-id></element-citation></ref><ref id="CR8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bondoc</surname><given-names>FY</given-names></name><name><surname>Bao</surname><given-names>Z</given-names></name><name><surname>Hu</surname><given-names>WY</given-names></name><name><surname>Gonzalez</surname><given-names>FJ</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>CS</given-names></name><name><surname>Hong</surname><given-names>JY</given-names></name></person-group><article-title>Acetone catabolism by cytochrome P450 2E1: studies with CYP2E1-null mice</article-title><source>Biochem Pharmacol</source><year>1999</year><volume>58</volume><fpage>461</fpage><lpage>463</lpage><?supplied-pmid 10424765?><pub-id pub-id-type="pmid">10424765</pub-id></element-citation></ref><ref id="CR9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chauvin</surname><given-names>JR</given-names></name><name><surname>Pratt</surname><given-names>DA</given-names></name></person-group><article-title>On the reactions of thiols, sulfenic acids, and sulfinic acids with hydrogen peroxide</article-title><source>Angew Chem Int Ed Engl</source><year>2017</year><volume>56</volume><fpage>6255</fpage><lpage>6259</lpage><?supplied-pmid 27933690?><pub-id pub-id-type="pmid">27933690</pub-id></element-citation></ref><ref id="CR10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Qin</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Lan</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name></person-group><article-title>Site-specific chemoproteomic profiling of targets of glyoxal</article-title><source>Future Med Chem</source><year>2019</year><volume>11</volume><fpage>2979</fpage><lpage>2987</lpage><?supplied-pmid 31663776?><pub-id pub-id-type="pmid">31663776</pub-id></element-citation></ref><ref id="CR11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Commerford</surname><given-names>SL</given-names></name><name><surname>Carsten</surname><given-names>AL</given-names></name><name><surname>Cronkite</surname><given-names>EP</given-names></name></person-group><article-title>Histone turnover within nonproliferating cells</article-title><source>Proc Natl Acad Sci USA</source><year>1982</year><volume>79</volume><fpage>1163</fpage><lpage>1165</lpage><?supplied-pmid 6951165?><pub-id pub-id-type="pmid">6951165</pub-id></element-citation></ref><ref id="CR12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cripps</surname><given-names>MJ</given-names></name><name><surname>Hanna</surname><given-names>K</given-names></name><name><surname>Lavilla</surname><given-names>C</given-names><suffix>Jr</suffix></name><name><surname>Sayers</surname><given-names>SR</given-names></name><name><surname>Caton</surname><given-names>PW</given-names></name><name><surname>Sims</surname><given-names>C</given-names></name><name><surname>De Girolamo</surname><given-names>L</given-names></name><name><surname>Sale</surname><given-names>C</given-names></name><name><surname>Turner</surname><given-names>MD</given-names></name></person-group><article-title>Carnosine scavenging of glucolipotoxic free radicals enhances insulin secretion and glucose uptake</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><fpage>13313</fpage><?supplied-pmid 29042678?><pub-id pub-id-type="pmid">29042678</pub-id></element-citation></ref><ref id="CR13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cryan</surname><given-names>JF</given-names></name><name><surname>O&#x02019;Riordan</surname><given-names>KJ</given-names></name><name><surname>Cowan</surname><given-names>CSM</given-names></name><name><surname>Sandhu</surname><given-names>KV</given-names></name><name><surname>Bastiaanssen</surname><given-names>TFS</given-names></name><name><surname>Boehme</surname><given-names>M</given-names></name><name><surname>Codagnone</surname><given-names>MG</given-names></name><name><surname>Cussotto</surname><given-names>S</given-names></name><name><surname>Fulling</surname><given-names>C</given-names></name><name><surname>Golubeva</surname><given-names>AV</given-names></name><etal/></person-group><article-title>The microbiota-gut-brain axis</article-title><source>Physiol Rev</source><year>2019</year><volume>99</volume><fpage>1877</fpage><lpage>2013</lpage><?supplied-pmid 31460832?><pub-id pub-id-type="pmid">31460832</pub-id></element-citation></ref><ref id="CR14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Hao</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>XD</given-names></name></person-group><article-title>Histone ketoamide adduction by 4-oxo-2-nonenal is a reversible posttranslational modification regulated by Sirt2</article-title><source>ACS Chem Biol</source><year>2017</year><volume>12</volume><fpage>47</fpage><lpage>51</lpage><?supplied-pmid 28103679?><pub-id pub-id-type="pmid">28103679</pub-id></element-citation></ref><ref id="CR15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuthbert</surname><given-names>GL</given-names></name><name><surname>Daujat</surname><given-names>S</given-names></name><name><surname>Snowden</surname><given-names>AW</given-names></name><name><surname>Erdjument-Bromage</surname><given-names>H</given-names></name><name><surname>Hagiwara</surname><given-names>T</given-names></name><name><surname>Yamada</surname><given-names>M</given-names></name><name><surname>Schneider</surname><given-names>R</given-names></name><name><surname>Gregory</surname><given-names>PD</given-names></name><name><surname>Tempst</surname><given-names>P</given-names></name><name><surname>Bannister</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Histone deimination antagonizes arginine methylation</article-title><source>Cell</source><year>2004</year><volume>118</volume><fpage>545</fpage><lpage>553</lpage><?supplied-pmid 15339660?><pub-id pub-id-type="pmid">15339660</pub-id></element-citation></ref><ref id="CR16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalmasso</surname><given-names>G</given-names></name><name><surname>Cougnoux</surname><given-names>A</given-names></name><name><surname>Delmas</surname><given-names>J</given-names></name><name><surname>Darfeuille-Michaud</surname><given-names>A</given-names></name><name><surname>Bonnet</surname><given-names>R</given-names></name></person-group><article-title>The bacterial genotoxin colibactin promotes colon tumor growth by modifying the tumor microenvironment</article-title><source>Gut Microbes</source><year>2014</year><volume>5</volume><fpage>675</fpage><lpage>680</lpage><?supplied-pmid 25483338?><pub-id pub-id-type="pmid">25483338</pub-id></element-citation></ref><ref id="CR17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Distler</surname><given-names>MG</given-names></name><name><surname>Palmer</surname><given-names>AA</given-names></name></person-group><article-title>Role of Glyoxalase 1 (Glo1) and methylglyoxal (MG) in behavior: recent advances and mechanistic insights</article-title><source>Front Genet</source><year>2012</year><volume>3</volume><fpage>250</fpage><?supplied-pmid 23181072?><pub-id pub-id-type="pmid">23181072</pub-id></element-citation></ref><ref id="CR18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doorn</surname><given-names>JA</given-names></name><name><surname>Petersen</surname><given-names>DR</given-names></name></person-group><article-title>Covalent modification of amino acid nucleophiles by the lipid peroxidation products 4-hydroxy-2-nonenal and 4-oxo-2-nonenal</article-title><source>Chem Res Toxicol</source><year>2002</year><volume>15</volume><fpage>1445</fpage><lpage>1450</lpage><?supplied-pmid 12437335?><pub-id pub-id-type="pmid">12437335</pub-id></element-citation></ref><ref id="CR19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drazic</surname><given-names>A</given-names></name><name><surname>Myklebust</surname><given-names>LM</given-names></name><name><surname>Ree</surname><given-names>R</given-names></name><name><surname>Arnesen</surname><given-names>T</given-names></name></person-group><article-title>The world of protein acetylation</article-title><source>Biochim Biophys Acta</source><year>2016</year><volume>1864</volume><fpage>1372</fpage><lpage>1401</lpage><?supplied-pmid 27296530?><pub-id pub-id-type="pmid">27296530</pub-id></element-citation></ref><ref id="CR20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drozak</surname><given-names>J</given-names></name><name><surname>Veiga-da-Cunha</surname><given-names>M</given-names></name><name><surname>Vertommen</surname><given-names>D</given-names></name><name><surname>Stroobant</surname><given-names>V</given-names></name><name><surname>Van Schaftingen</surname><given-names>E</given-names></name></person-group><article-title>Molecular identification of carnosine synthase as ATP-grasp domain-containing protein 1 (ATPGD1)</article-title><source>J Biol Chem</source><year>2010</year><volume>285</volume><fpage>9346</fpage><lpage>9356</lpage><?supplied-pmid 20097752?><pub-id pub-id-type="pmid">20097752</pub-id></element-citation></ref><ref id="CR21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>X</given-names></name><name><surname>Kelsen</surname><given-names>SG</given-names></name><name><surname>Merali</surname><given-names>S</given-names></name></person-group><article-title>Proteomic analysis of oxidative stress-responsive proteins in human pneumocytes: insight into the regulation of DJ-1 expression</article-title><source>J Proteome Res</source><year>2008</year><volume>7</volume><fpage>4955</fpage><lpage>4961</lpage><?supplied-pmid 18817430?><pub-id pub-id-type="pmid">18817430</pub-id></element-citation></ref><ref id="CR22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erler</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Petridis</surname><given-names>L</given-names></name><name><surname>Cheng</surname><given-names>X</given-names></name><name><surname>Smith</surname><given-names>JC</given-names></name><name><surname>Langowski</surname><given-names>J</given-names></name></person-group><article-title>The role of histone tails in the nucleosome: a computational study</article-title><source>Biophys J</source><year>2014</year><volume>107</volume><fpage>2911</fpage><lpage>2922</lpage><?supplied-pmid 25517156?><pub-id pub-id-type="pmid">25517156</pub-id></element-citation></ref><ref id="CR23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Etchegaray</surname><given-names>JP</given-names></name><name><surname>Mostoslavsky</surname><given-names>R</given-names></name></person-group><article-title>Interplay between metabolism and epigenetics: A nuclear adaptation to environmental changes</article-title><source>Mol Cell</source><year>2016</year><volume>62</volume><fpage>695</fpage><lpage>711</lpage><?supplied-pmid 27259202?><pub-id pub-id-type="pmid">27259202</pub-id></element-citation></ref><ref id="CR24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fournet</surname><given-names>M</given-names></name><name><surname>Bont&#x000e9;</surname><given-names>F</given-names></name><name><surname>Desmouli&#x000e8;re</surname><given-names>A</given-names></name></person-group><article-title>Glycation damage: A possible hub for major pathophysiological disorders and aging</article-title><source>Aging Dis</source><year>2018</year><volume>9</volume><fpage>880</fpage><lpage>900</lpage><?supplied-pmid 30271665?><pub-id pub-id-type="pmid">30271665</pub-id></element-citation></ref><ref id="CR25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaffney</surname><given-names>DO</given-names></name><name><surname>Jennings</surname><given-names>EQ</given-names></name><name><surname>Anderson</surname><given-names>CC</given-names></name><name><surname>Marentette</surname><given-names>JO</given-names></name><name><surname>Shi</surname><given-names>T</given-names></name><name><surname>Schou Oxvig</surname><given-names>AM</given-names></name><name><surname>Streeter</surname><given-names>MD</given-names></name><name><surname>Johannsen</surname><given-names>M</given-names></name><name><surname>Spiegel</surname><given-names>DA</given-names></name><name><surname>Chapman</surname><given-names>E</given-names></name><etal/></person-group><article-title>Non-enzymatic lysine lactoylation of glycolytic enzymes</article-title><source>Cell Chem Bio</source><year>2019</year><pub-id pub-id-type="doi">10.1016/j.chembiol.2019.11.005</pub-id></element-citation></ref><ref id="CR26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galligan</surname><given-names>JJ</given-names></name><name><surname>Rose</surname><given-names>KL</given-names></name><name><surname>Beavers</surname><given-names>WN</given-names></name><name><surname>Hill</surname><given-names>S</given-names></name><name><surname>Tallman</surname><given-names>KA</given-names></name><name><surname>Tansey</surname><given-names>WP</given-names></name><name><surname>Marnett</surname><given-names>LJ</given-names></name></person-group><article-title>Stable histone adduction by 4-oxo-2-nonenal: a potential link between oxidative stress and epigenetics</article-title><source>J Am Chem Soc</source><year>2014</year><volume>136</volume><fpage>11864</fpage><lpage>11866</lpage><?supplied-pmid 25099620?><pub-id pub-id-type="pmid">25099620</pub-id></element-citation></ref><ref id="CR27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galligan</surname><given-names>JJ</given-names></name><name><surname>Wepy</surname><given-names>JA</given-names></name><name><surname>Streeter</surname><given-names>MD</given-names></name><name><surname>Kingsley</surname><given-names>PJ</given-names></name><name><surname>Mitchener</surname><given-names>MM</given-names></name><name><surname>Wauchope</surname><given-names>OR</given-names></name><name><surname>Beavers</surname><given-names>WN</given-names></name><name><surname>Rose</surname><given-names>KL</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Spiegel</surname><given-names>DA</given-names></name><etal/></person-group><article-title>Methylglyoxal-derived posttranslational arginine modifications are abundant histone marks</article-title><source>Proc Natl Acad Sci U S A</source><year>2018</year><volume>115</volume><fpage>9228</fpage><lpage>9233</lpage><?supplied-pmid 30150385?><pub-id pub-id-type="pmid">30150385</pub-id></element-citation></ref><ref id="CR28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-Gim&#x000e9;nez</surname><given-names>JL</given-names></name><name><surname>&#x000d2;laso</surname><given-names>G</given-names></name><name><surname>Hake</surname><given-names>SB</given-names></name><name><surname>B&#x000f6;nisch</surname><given-names>C</given-names></name><name><surname>Wiedemann</surname><given-names>SM</given-names></name><name><surname>Markovic</surname><given-names>J</given-names></name><name><surname>Das&#x000ed;</surname><given-names>F</given-names></name><name><surname>Gimeno</surname><given-names>A</given-names></name><name><surname>P&#x000e9;rez-Quilis</surname><given-names>C</given-names></name><name><surname>Palacios</surname><given-names>O</given-names></name><etal/></person-group><article-title>Histone H3 glutathionylation in proliferating mammalian cells destabilizes nucleosomal structure</article-title><source>Antioxid Redox Signal</source><year>2013</year><volume>19</volume><fpage>1305</fpage><lpage>1320</lpage><?supplied-pmid 23541030?><pub-id pub-id-type="pmid">23541030</pub-id></element-citation></ref><ref id="CR29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geerlings</surname><given-names>SE</given-names></name><name><surname>Hoepelman</surname><given-names>AI</given-names></name></person-group><article-title>Immune dysfunction in patients with diabetes mellitus (DM)</article-title><source>FEMS Immunol Med Microbiol</source><year>1999</year><volume>26</volume><fpage>259</fpage><lpage>265</lpage><?supplied-pmid 10575137?><pub-id pub-id-type="pmid">10575137</pub-id></element-citation></ref><ref id="CR30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greetham</surname><given-names>D</given-names></name><name><surname>Vickerstaff</surname><given-names>J</given-names></name><name><surname>Shenton</surname><given-names>D</given-names></name><name><surname>Perrone</surname><given-names>GG</given-names></name><name><surname>Dawes</surname><given-names>IW</given-names></name><name><surname>Grant</surname><given-names>CM</given-names></name></person-group><article-title>Thioredoxins function as deglutathionylase enzymes in the yeast <italic>Saccharomyces cerevisiae</italic></article-title><source>BMC Biochem</source><year>2010</year><volume>11</volume><fpage>3</fpage><?supplied-pmid 20074363?><pub-id pub-id-type="pmid">20074363</pub-id></element-citation></ref><ref id="CR31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>CJ</given-names></name><name><surname>Chang</surname><given-names>FY</given-names></name><name><surname>Wyche</surname><given-names>TP</given-names></name><name><surname>Backus</surname><given-names>KM</given-names></name><name><surname>Acker</surname><given-names>TM</given-names></name><name><surname>Funabashi</surname><given-names>M</given-names></name><name><surname>Taketani</surname><given-names>M</given-names></name><name><surname>Donia</surname><given-names>MS</given-names></name><name><surname>Nayfach</surname><given-names>S</given-names></name><name><surname>Pollard</surname><given-names>KS</given-names></name><etal/></person-group><article-title>Discovery of reactive microbiota-derived metabolites that inhibit host proteases</article-title><source>Cell</source><year>2017</year><volume>168</volume><fpage>517</fpage><lpage>526</lpage><?supplied-pmid 28111075?><pub-id pub-id-type="pmid">28111075</pub-id></element-citation></ref><ref id="CR32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hake</surname><given-names>SB</given-names></name><name><surname>Allis</surname><given-names>CD</given-names></name></person-group><article-title>Histone H3 variants and their potential role in indexing mammalian genomes: the &#x0201c;H3 barcode hypothesis&#x0201d;</article-title><source>Proc Natl Acad Sci USA</source><year>2006</year><volume>103</volume><fpage>6428</fpage><lpage>6435</lpage><?supplied-pmid 16571659?><pub-id pub-id-type="pmid">16571659</pub-id></element-citation></ref><ref id="CR33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hand</surname><given-names>CE</given-names></name><name><surname>Honek</surname><given-names>JF</given-names></name></person-group><article-title>Biological chemistry of naturally occurring thiols of microbial and marine origin</article-title><source>J Nat Prod</source><year>2005</year><volume>68</volume><fpage>293</fpage><lpage>308</lpage><?supplied-pmid 15730267?><pub-id pub-id-type="pmid">15730267</pub-id></element-citation></ref><ref id="CR34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harmel</surname><given-names>R</given-names></name><name><surname>Fiedler</surname><given-names>D</given-names></name></person-group><article-title>Features and regulation of non-enzymatic post-translational modifications</article-title><source>Nat Chem Biol</source><year>2018</year><volume>14</volume><fpage>244</fpage><lpage>252</lpage><?supplied-pmid 29443975?><pub-id pub-id-type="pmid">29443975</pub-id></element-citation></ref><ref id="CR35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hellwig</surname><given-names>M</given-names></name><name><surname>Henle</surname><given-names>T</given-names></name></person-group><article-title>Baking, ageing, diabetes: a short history of the Maillard reaction</article-title><source>Angew Chem Int Ed Engl</source><year>2014</year><volume>53</volume><issue>39</issue><fpage>10316</fpage><lpage>10329</lpage><?supplied-pmid 25044982?><pub-id pub-id-type="pmid">25044982</pub-id></element-citation></ref><ref id="CR36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakubowski</surname><given-names>H</given-names></name></person-group><article-title>Homocysteine thiolactone: metabolic origin and protein homocysteinylation in humans</article-title><source>J Nutr</source><year>2000</year><volume>130</volume><fpage>377S</fpage><lpage>381S</lpage><?supplied-pmid 10721911?><pub-id pub-id-type="pmid">10721911</pub-id></element-citation></ref><ref id="CR37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janke</surname><given-names>R</given-names></name><name><surname>Dodson</surname><given-names>AE</given-names></name><name><surname>Rine</surname><given-names>J</given-names></name></person-group><article-title>Metabolism and epigenetics</article-title><source>Annu Rev Cell Dev Biol</source><year>2015</year><volume>31</volume><fpage>473</fpage><lpage>496</lpage><?supplied-pmid 26359776?><pub-id pub-id-type="pmid">26359776</pub-id></element-citation></ref><ref id="CR38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaramillo</surname><given-names>R</given-names></name><name><surname>Shuck</surname><given-names>SC</given-names></name><name><surname>Chan</surname><given-names>YS</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Bates</surname><given-names>SE</given-names></name><name><surname>Lim</surname><given-names>PP</given-names></name><name><surname>Tamae</surname><given-names>D</given-names></name><name><surname>Lacoste</surname><given-names>S</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>TR</given-names></name><name><surname>Termini</surname><given-names>J</given-names></name></person-group><article-title>DNA Advanced glycation end products (DNA-AGEs) are elevated in urine and tissue in an animal model of type 2 diabetes</article-title><source>Chem Res Toxicol</source><year>2017</year><volume>30</volume><fpage>689</fpage><lpage>698</lpage><?supplied-pmid 28107623?><pub-id pub-id-type="pmid">28107623</pub-id></element-citation></ref><ref id="CR39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jawahar</surname><given-names>MC</given-names></name><name><surname>Murgatroyd</surname><given-names>C</given-names></name><name><surname>Harrison</surname><given-names>EL</given-names></name><name><surname>Baune</surname><given-names>BT</given-names></name></person-group><article-title>Epigenetic alterations following early postnatal stress: a review on novel aetiological mechanisms of common psychiatric disorders</article-title><source>Clin Epigenet</source><year>2015</year><volume>7</volume><fpage>122</fpage></element-citation></ref><ref id="CR40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenuwein</surname><given-names>T</given-names></name><name><surname>Allis</surname><given-names>CD</given-names></name></person-group><article-title>Translating the histone code</article-title><source>Science</source><year>2001</year><volume>293</volume><fpage>1074</fpage><lpage>1080</lpage><?supplied-pmid 11498575?><pub-id pub-id-type="pmid">11498575</pub-id></element-citation></ref><ref id="CR41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>T</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Taghizadeh</surname><given-names>K</given-names></name><name><surname>Dong</surname><given-names>M</given-names></name><name><surname>Dedon</surname><given-names>PC</given-names></name></person-group><article-title>N-formylation of lysine in histone proteins as a secondary modification arising from oxidative DNA damage</article-title><source>Proc Natl Acad Sci USA</source><year>2007</year><volume>104</volume><fpage>60</fpage><lpage>65</lpage><?supplied-pmid 17190813?><pub-id pub-id-type="pmid">17190813</pub-id></element-citation></ref><ref id="CR42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kansanen</surname><given-names>E</given-names></name><name><surname>Kuosmanen</surname><given-names>SM</given-names></name><name><surname>Leinonen</surname><given-names>H</given-names></name><name><surname>Levonen</surname><given-names>AL</given-names></name></person-group><article-title>The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer</article-title><source>Redox Biol</source><year>2013</year><volume>1</volume><fpage>45</fpage><lpage>49</lpage><?supplied-pmid 24024136?><pub-id pub-id-type="pmid">24024136</pub-id></element-citation></ref><ref id="CR43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawai</surname><given-names>Y</given-names></name><name><surname>Gardu&#x000f1;o</surname><given-names>L</given-names></name><name><surname>Theodore</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Arinze</surname><given-names>IJ</given-names></name></person-group><article-title>Acetylation-deacetylation of the transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) regulates its transcriptional activity and nucleocytoplasmic localization</article-title><source>J Biol Chem</source><year>2011</year><volume>286</volume><fpage>7629</fpage><lpage>7640</lpage><?supplied-pmid 21196497?><pub-id pub-id-type="pmid">21196497</pub-id></element-citation></ref><ref id="CR44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keum</surname><given-names>YS</given-names></name></person-group><article-title>Regulation of the Keap1/Nrf2 system by chemopreventive sulforaphane: implications of posttranslational modifications</article-title><source>Ann N Y Acad Sci</source><year>2011</year><volume>1229</volume><fpage>184</fpage><lpage>189</lpage><?supplied-pmid 21793854?><pub-id pub-id-type="pmid">21793854</pub-id></element-citation></ref><ref id="CR45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>NY</given-names></name><name><surname>Goddard</surname><given-names>TN</given-names></name><name><surname>Sohn</surname><given-names>S</given-names></name><name><surname>Spiegel</surname><given-names>DA</given-names></name><name><surname>Crawford</surname><given-names>JM</given-names></name></person-group><article-title>Biocatalytic reversal of advanced glycation end product modification</article-title><source>Chembiochem</source><year>2019</year><volume>20</volume><fpage>2402</fpage><lpage>2410</lpage><?supplied-pmid 31013547?><pub-id pub-id-type="pmid">31013547</pub-id></element-citation></ref><ref id="CR46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kopelman</surname><given-names>P</given-names></name></person-group><article-title>Health risks associated with overweight and obesity</article-title><source>Obes Rev</source><year>2007</year><volume>1</volume><fpage>13</fpage><lpage>17</lpage></element-citation></ref><ref id="CR47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Kwon</surname><given-names>K</given-names></name><name><surname>Jang</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>C</given-names></name><name><surname>Baek</surname><given-names>K</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>C</given-names></name></person-group><article-title>Human DJ-1 and its homologs are novel glyoxalases</article-title><source>Hum Mol Genet</source><year>2012</year><volume>21</volume><fpage>3215</fpage><lpage>3225</lpage><?supplied-pmid 22523093?><pub-id pub-id-type="pmid">22523093</pub-id></element-citation></ref><ref id="CR48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name></person-group><article-title>Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective</article-title><source>J Neurol Sci</source><year>2012</year><volume>317</volume><fpage>1</fpage><lpage>5</lpage><?supplied-pmid 22410257?><pub-id pub-id-type="pmid">22410257</pub-id></element-citation></ref><ref id="CR49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Quan</surname><given-names>G</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Ding</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Hardwidge</surname><given-names>PR</given-names></name><name><surname>Ren</surname><given-names>W</given-names></name><name><surname>Zhu</surname><given-names>G</given-names></name></person-group><article-title>Effects of metabolites derived from gut microbiota and hosts on pathogens</article-title><source>Front Cell Infect Microbiol</source><year>2018</year><volume>8</volume><fpage>314</fpage><?supplied-pmid 30276161?><pub-id pub-id-type="pmid">30276161</pub-id></element-citation></ref><ref id="CR50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linetsky</surname><given-names>M</given-names></name><name><surname>Shipova</surname><given-names>E</given-names></name><name><surname>Cheng</surname><given-names>R</given-names></name><name><surname>Ortwerth</surname><given-names>BJ</given-names></name></person-group><article-title>Glycation by ascorbic acid oxidation products leads to the aggregation of lens proteins</article-title><source>Biochim Biophys Acta</source><year>2007</year><volume>1782</volume><fpage>22</fpage><lpage>34</lpage><?supplied-pmid 18023423?><pub-id pub-id-type="pmid">18023423</pub-id></element-citation></ref><ref id="CR51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Little</surname><given-names>WC</given-names></name><name><surname>Zile</surname><given-names>MR</given-names></name><name><surname>Kitzman</surname><given-names>DW</given-names></name><name><surname>Hundley</surname><given-names>WG</given-names></name><name><surname>O&#x02019;Brien</surname><given-names>TX</given-names></name><name><surname>Degroof</surname><given-names>RC</given-names></name></person-group><article-title>The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure</article-title><source>J Card Fail</source><year>2005</year><volume>11</volume><fpage>191</fpage><lpage>195</lpage><?supplied-pmid 15812746?><pub-id pub-id-type="pmid">15812746</pub-id></element-citation></ref><ref id="CR52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maksimovic</surname><given-names>I</given-names></name><name><surname>Ray</surname><given-names>D</given-names></name><name><surname>Zheng</surname><given-names>Q</given-names></name><name><surname>David</surname><given-names>Y</given-names></name></person-group><article-title>Utilizing intein trans-splicing for in vivo generation of site-specifically modified proteins</article-title><source>Methods Enzymol</source><year>2019</year><volume>626</volume><fpage>203</fpage><lpage>222</lpage><?supplied-pmid 31606075?><pub-id pub-id-type="pmid">31606075</pub-id></element-citation></ref><ref id="CR53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marinho</surname><given-names>HS</given-names></name><name><surname>Real</surname><given-names>C</given-names></name><name><surname>Cyrne</surname><given-names>L</given-names></name><name><surname>Soares</surname><given-names>H</given-names></name><name><surname>Antunes</surname><given-names>F</given-names></name></person-group><article-title>Hydrogen peroxide sensing, signaling and regulation of transcription factors</article-title><source>Redox Biol</source><year>2014</year><volume>2</volume><fpage>535</fpage><lpage>562</lpage><?supplied-pmid 24634836?><pub-id pub-id-type="pmid">24634836</pub-id></element-citation></ref><ref id="CR54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matafome</surname><given-names>P</given-names></name><name><surname>Sena</surname><given-names>C</given-names></name><name><surname>Sei&#x000e7;a</surname><given-names>R</given-names></name></person-group><article-title>Methylglyoxal, obesity, and diabetes</article-title><source>Endocrine</source><year>2013</year><volume>43</volume><fpage>472</fpage><lpage>484</lpage><?supplied-pmid 22983866?><pub-id pub-id-type="pmid">22983866</pub-id></element-citation></ref><ref id="CR55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuda</surname><given-names>R</given-names></name><name><surname>Bi</surname><given-names>C</given-names></name><name><surname>Anguizola</surname><given-names>J</given-names></name><name><surname>Sobansky</surname><given-names>M</given-names></name><name><surname>Rodriguez</surname><given-names>E</given-names></name><name><surname>Vargas Badilla</surname><given-names>J</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Hage</surname><given-names>B</given-names></name><name><surname>Hage</surname><given-names>DS</given-names></name></person-group><article-title>Studies of metabolite-protein interactions: a review</article-title><source>J Chromatogr B Analyt Technol Biomed Life Sci</source><year>2013</year><volume>966</volume><fpage>48</fpage><lpage>58</lpage><?supplied-pmid 24321277?><pub-id pub-id-type="pmid">24321277</pub-id></element-citation></ref><ref id="CR56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuda</surname><given-names>N</given-names></name><name><surname>Kimura</surname><given-names>M</given-names></name><name><surname>Queliconi</surname><given-names>BB</given-names></name><name><surname>Kojima</surname><given-names>W</given-names></name><name><surname>Mishima</surname><given-names>M</given-names></name><name><surname>Takagi</surname><given-names>K</given-names></name><name><surname>Koyano</surname><given-names>F</given-names></name><name><surname>Yamano</surname><given-names>K</given-names></name><name><surname>Mizushima</surname><given-names>T</given-names></name><name><surname>Ito</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Parkinson&#x02019;s disease-related DJ-1 functions in thiol quality control against aldehyde attack <italic>in vitro</italic></article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><fpage>12816</fpage><?supplied-pmid 28993701?><pub-id pub-id-type="pmid">28993701</pub-id></element-citation></ref><ref id="CR57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>May-Zhang</surname><given-names>LS</given-names></name><name><surname>Yermalitsky</surname><given-names>V</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Pleasent</surname><given-names>T</given-names></name><name><surname>Borja</surname><given-names>MS</given-names></name><name><surname>Oda</surname><given-names>MN</given-names></name><name><surname>Jerome</surname><given-names>WG</given-names></name><name><surname>Yancey</surname><given-names>PG</given-names></name><name><surname>Linton</surname><given-names>MF</given-names></name><name><surname>Davies</surname><given-names>SS</given-names></name></person-group><article-title>Modification by isolevuglandins, highly reactive &#x003b3;-ketoaldehydes, deleteriously alters high-density lipoprotein structure and function</article-title><source>J Biol Chem</source><year>2018</year><volume>293</volume><fpage>9176</fpage><lpage>9187</lpage><?supplied-pmid 29712723?><pub-id pub-id-type="pmid">29712723</pub-id></element-citation></ref><ref id="CR58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGinty</surname><given-names>RK</given-names></name><name><surname>Tan</surname><given-names>S</given-names></name></person-group><article-title>Nucleosome structure and function</article-title><source>Chem Rev</source><year>2015</year><volume>115</volume><fpage>2255</fpage><lpage>2273</lpage><?supplied-pmid 25495456?><pub-id pub-id-type="pmid">25495456</pub-id></element-citation></ref><ref id="CR59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>D</given-names><suffix>3rd</suffix></name><name><surname>Ritchey</surname><given-names>LE</given-names></name><name><surname>Park</surname><given-names>H</given-names></name><name><surname>Babitzke</surname><given-names>P</given-names></name><name><surname>Assmann</surname><given-names>SM</given-names></name><name><surname>Bevilacqua</surname><given-names>PC</given-names></name></person-group><article-title>Glyoxals as in vivo RNA structural probes of guanine base-pairing</article-title><source>RNA</source><year>2018</year><volume>24</volume><fpage>114</fpage><lpage>124</lpage><?supplied-pmid 29030489?><pub-id pub-id-type="pmid">29030489</pub-id></element-citation></ref><ref id="CR60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moellering</surname><given-names>RE</given-names></name><name><surname>Cravatt</surname><given-names>BF</given-names></name></person-group><article-title>Functional lysine modification by an intrinsically reactive primary glycolytic metabolite</article-title><source>Science</source><year>2013</year><volume>341</volume><fpage>549</fpage><lpage>553</lpage><?supplied-pmid 23908237?><pub-id pub-id-type="pmid">23908237</pub-id></element-citation></ref><ref id="CR61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montellier</surname><given-names>E</given-names></name><name><surname>Gaucher</surname><given-names>J</given-names></name></person-group><article-title>Targeting the interplay between metabolism and epigenetics in cancer</article-title><source>Curr Opin Oncol</source><year>2019</year><volume>31</volume><fpage>92</fpage><lpage>99</lpage><?supplied-pmid 30562315?><pub-id pub-id-type="pmid">30562315</pub-id></element-citation></ref><ref id="CR62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nair</surname><given-names>DN</given-names></name><name><surname>Prasad</surname><given-names>R</given-names></name><name><surname>Singhal</surname><given-names>N</given-names></name><name><surname>Bhattacharjee</surname><given-names>M</given-names></name><name><surname>Sudhakar</surname><given-names>R</given-names></name><name><surname>Singh</surname><given-names>P</given-names></name><name><surname>Thanumalayan</surname><given-names>S</given-names></name><name><surname>Kiran</surname><given-names>U</given-names></name><name><surname>Sharma</surname><given-names>Y</given-names></name><name><surname>Sijwali</surname><given-names>PS</given-names></name></person-group><article-title>A conserved human DJ1-subfamily motif (DJSM) is critical for anti-oxidative and deglycase activities of Plasmodium falciparum DJ1</article-title><source>Mol Biochem Parasitol</source><year>2018</year><volume>222</volume><fpage>70</fpage><lpage>80</lpage><?supplied-pmid 29753659?><pub-id pub-id-type="pmid">29753659</pub-id></element-citation></ref><ref id="CR63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>N&#x000e4;sstr&#x000f6;m</surname><given-names>T</given-names></name><name><surname>Fagerqvist</surname><given-names>T</given-names></name><name><surname>Barbu</surname><given-names>M</given-names></name><name><surname>Karlsson</surname><given-names>M</given-names></name><name><surname>Nikolajeff</surname><given-names>F</given-names></name><name><surname>Kasrayan</surname><given-names>A</given-names></name><name><surname>Ekberg</surname><given-names>M</given-names></name><name><surname>Lannfelt</surname><given-names>L</given-names></name><name><surname>Ingelsson</surname><given-names>M</given-names></name><name><surname>Bergstr&#x000f6;m</surname><given-names>J</given-names></name></person-group><article-title>The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of &#x003b1;-synuclein oligomers with distinct biochemical, morphological, and functional properties</article-title><source>Free Radic Biol Med</source><year>2011</year><volume>50</volume><fpage>428</fpage><lpage>437</lpage><?supplied-pmid 21130160?><pub-id pub-id-type="pmid">21130160</pub-id></element-citation></ref><ref id="CR64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obata</surname><given-names>T</given-names></name></person-group><article-title>Diabetes and semicarbazide-sensitive amine oxidase (SSAO) activity: a review</article-title><source>Life Sci</source><year>2006</year><volume>79</volume><fpage>417</fpage><lpage>422</lpage><?supplied-pmid 16487546?><pub-id pub-id-type="pmid">16487546</pub-id></element-citation></ref><ref id="CR65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ochs</surname><given-names>R</given-names></name></person-group><article-title>An idea to explore: understanding redox reactions in biochemistry</article-title><source>Biochem Mol Biol Educ</source><year>2019</year><volume>47</volume><fpage>25</fpage><lpage>28</lpage><?supplied-pmid 30467943?><pub-id pub-id-type="pmid">30467943</pub-id></element-citation></ref><ref id="CR66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parrish</surname><given-names>JP</given-names></name><name><surname>Kastrinsky</surname><given-names>DB</given-names></name><name><surname>Wolkenberg</surname><given-names>SE</given-names></name><name><surname>Igarashi</surname><given-names>Y</given-names></name><name><surname>Boger</surname><given-names>DL</given-names></name></person-group><article-title>NA alkylation properties of yatakemycin</article-title><source>J Am Chem Soc</source><year>2003</year><volume>125</volume><fpage>10971</fpage><lpage>10976</lpage><?supplied-pmid 12952479?><pub-id pub-id-type="pmid">12952479</pub-id></element-citation></ref><ref id="CR67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poole</surname><given-names>LB</given-names></name></person-group><article-title>The basics of thiols and cysteines in redox biology and chemistry</article-title><source>Free Radic Biol Med</source><year>2015</year><volume>80</volume><fpage>148</fpage><lpage>157</lpage><?supplied-pmid 25433365?><pub-id pub-id-type="pmid">25433365</pub-id></element-citation></ref><ref id="CR68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raiber</surname><given-names>EA</given-names></name><name><surname>Portella</surname><given-names>G</given-names></name><name><surname>Mart&#x000ed;nez Cuesta</surname><given-names>S</given-names></name><name><surname>Hardisty</surname><given-names>R</given-names></name><name><surname>Murat</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Iurlaro</surname><given-names>M</given-names></name><name><surname>Dean</surname><given-names>W</given-names></name><name><surname>Spindel</surname><given-names>J</given-names></name><name><surname>Beraldi</surname><given-names>D</given-names></name><etal/></person-group><article-title>5-Formylcytosine organizes nucleosomes and forms Schiff base interactions with histones in mouse embryonic stem cells</article-title><source>Nat Chem</source><year>2018</year><volume>10</volume><fpage>1258</fpage><lpage>1266</lpage><?supplied-pmid 30349137?><pub-id pub-id-type="pmid">30349137</pub-id></element-citation></ref><ref id="CR69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reid</surname><given-names>MA</given-names></name><name><surname>Dai</surname><given-names>Z</given-names></name><name><surname>Locasale</surname><given-names>JW</given-names></name></person-group><article-title>The impact of cellular metabolism on chromatin dynamics and epigenetics</article-title><source>Nat Cell Biol</source><year>2017</year><volume>19</volume><fpage>1298</fpage><lpage>1306</lpage><?supplied-pmid 29058720?><pub-id pub-id-type="pmid">29058720</pub-id></element-citation></ref><ref id="CR70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Repici</surname><given-names>M</given-names></name><name><surname>Giorgini</surname><given-names>F</given-names></name></person-group><article-title>DJ-1 in Parkinson&#x02019;s disease: Clinical insights and therapeutic perspectives</article-title><source>J Clin Med</source><year>2019</year><volume>8</volume><fpage>1377</fpage></element-citation></ref><ref id="CR71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richarme</surname><given-names>G</given-names></name><name><surname>Dairou</surname><given-names>J</given-names></name></person-group><article-title>Parkinsonism-associated protein DJ-1 is a <italic>bona fide</italic> deglycase</article-title><source>Biochem Biophys Res Commun</source><year>2017</year><volume>483</volume><fpage>387</fpage><lpage>391</lpage><?supplied-pmid 28013050?><pub-id pub-id-type="pmid">28013050</pub-id></element-citation></ref><ref id="CR72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richarme</surname><given-names>G</given-names></name><name><surname>Mihoub</surname><given-names>M</given-names></name><name><surname>Dairou</surname><given-names>J</given-names></name><name><surname>Bui</surname><given-names>LC</given-names></name><name><surname>Leger</surname><given-names>T</given-names></name><name><surname>Lamouri</surname><given-names>A</given-names></name></person-group><article-title>Parkinsonism-associated protein DJ-1/Park7 is a major protein deglycase that repairs methylglyoxal- and glyoxal-glycated cysteine, arginine, and lysine residues</article-title><source>J Biol Chem</source><year>2015</year><volume>290</volume><fpage>1885</fpage><lpage>1897</lpage><?supplied-pmid 25416785?><pub-id pub-id-type="pmid">25416785</pub-id></element-citation></ref><ref id="CR73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richarme</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Mihoub</surname><given-names>M</given-names></name><name><surname>Abdallah</surname><given-names>J</given-names></name><name><surname>Leger</surname><given-names>T</given-names></name><name><surname>Joly</surname><given-names>N</given-names></name><name><surname>Liebart</surname><given-names>JC</given-names></name><name><surname>Jurkunas</surname><given-names>UV</given-names></name><name><surname>Nadal</surname><given-names>M</given-names></name><name><surname>Bouloc</surname><given-names>P</given-names></name><etal/></person-group><article-title>Guanine glycation repair by DJ-1/Park7 and its bacterial homologs</article-title><source>Science</source><year>2017</year><volume>357</volume><fpage>208</fpage><lpage>211</lpage><?supplied-pmid 28596309?><pub-id pub-id-type="pmid">28596309</pub-id></element-citation></ref><ref id="CR74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rinschen</surname><given-names>MM</given-names></name><name><surname>Ivanisevic</surname><given-names>J</given-names></name><name><surname>Giera</surname><given-names>M</given-names></name><name><surname>Siuzdak</surname><given-names>G</given-names></name></person-group><article-title>Identification of bioactive metabolites using activity metabolomics</article-title><source>Nat Rev Mol Cell Biol</source><year>2019</year><volume>20</volume><fpage>353</fpage><lpage>367</lpage><?supplied-pmid 30814649?><pub-id pub-id-type="pmid">30814649</pub-id></element-citation></ref><ref id="CR75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rydberg</surname><given-names>B</given-names></name><name><surname>Lindahl</surname><given-names>T</given-names></name></person-group><article-title>Nonenzymatic methylation of DNA by the intracellular methyl group donor S-adenosyl-L-methionine is a potentially mutagenic reaction</article-title><source>EMBO J</source><year>1982</year><volume>1</volume><fpage>211</fpage><lpage>216</lpage><?supplied-pmid 7188181?><pub-id pub-id-type="pmid">7188181</pub-id></element-citation></ref><ref id="CR76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanghvi</surname><given-names>VR</given-names></name><name><surname>Leibold</surname><given-names>J</given-names></name><name><surname>Mina</surname><given-names>M</given-names></name><name><surname>Mohan</surname><given-names>P</given-names></name><name><surname>Berishaj</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Miele</surname><given-names>MM</given-names></name><name><surname>Lailler</surname><given-names>N</given-names></name><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>de Stanchina</surname><given-names>E</given-names></name><etal/></person-group><article-title>The oncogenic action of NRF2 depends on de-glycation by fructosamine-3-kinase</article-title><source>Cell</source><year>2019</year><volume>178</volume><fpage>807</fpage><lpage>819</lpage><?supplied-pmid 31398338?><pub-id pub-id-type="pmid">31398338</pub-id></element-citation></ref><ref id="CR77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schalkwijk</surname><given-names>CG</given-names></name><name><surname>Stehouwer</surname><given-names>CDA</given-names></name></person-group><article-title>Methylglyoxal, a highly reactive dicarbonyl compound, in diabetes, its vascular complications, and other age-related diseases</article-title><source>Physiol Rev</source><year>2020</year><volume>100</volume><fpage>407</fpage><lpage>461</lpage><?supplied-pmid 31539311?><pub-id pub-id-type="pmid">31539311</pub-id></element-citation></ref><ref id="CR78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schumacker</surname><given-names>PT</given-names></name></person-group><article-title>Reactive oxygen species in cancer cells: live by the sword, die by the sword</article-title><source>Cancer Cell</source><year>2006</year><volume>10</volume><fpage>175</fpage><lpage>176</lpage><?supplied-pmid 16959608?><pub-id pub-id-type="pmid">16959608</pub-id></element-citation></ref><ref id="CR79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shuck</surname><given-names>SC</given-names></name><name><surname>Wuenschell</surname><given-names>GE</given-names></name><name><surname>Termini</surname><given-names>JS</given-names></name></person-group><article-title>Product studies and mechanistic analysis of the reaction of methylglyoxal with deoxyguanosine</article-title><source>Chem Res Toxicol</source><year>2018</year><volume>31</volume><fpage>105</fpage><lpage>115</lpage><?supplied-pmid 29363306?><pub-id pub-id-type="pmid">29363306</pub-id></element-citation></ref><ref id="CR80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shuker</surname><given-names>DE</given-names></name><name><surname>Prevost</surname><given-names>V</given-names></name><name><surname>Friesen</surname><given-names>MD</given-names></name><name><surname>Lin</surname><given-names>D</given-names></name><name><surname>Ohshima</surname><given-names>H</given-names></name><name><surname>Bartsch</surname><given-names>H</given-names></name></person-group><article-title>Urinary markers for measuring exposure to endogenous and exogenous alkylating agents and precursors</article-title><source>Environ Health Perspect</source><year>1993</year><volume>99</volume><fpage>33</fpage><lpage>37</lpage><?supplied-pmid 8319651?><pub-id pub-id-type="pmid">8319651</pub-id></element-citation></ref><ref id="CR81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>R</given-names></name><name><surname>Barden</surname><given-names>A</given-names></name><name><surname>Mori</surname><given-names>T</given-names></name><name><surname>Beilin</surname><given-names>L</given-names></name></person-group><article-title>Advanced glycation end-products: a review</article-title><source>Diabetologia</source><year>2001</year><volume>44</volume><fpage>129</fpage><lpage>146</lpage><?supplied-pmid 11270668?><pub-id pub-id-type="pmid">11270668</pub-id></element-citation></ref><ref id="CR82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spiro</surname><given-names>RG</given-names></name></person-group><article-title>Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds</article-title><source>Glycobiology</source><year>2002</year><volume>12</volume><fpage>43R</fpage><lpage>56R</lpage><?supplied-pmid 12042244?><pub-id pub-id-type="pmid">12042244</pub-id></element-citation></ref><ref id="CR83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>R</given-names></name><name><surname>Fu</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>K</given-names></name><name><surname>Tian</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Tallman</surname><given-names>KA</given-names></name><name><surname>Porter</surname><given-names>NA</given-names></name><name><surname>Liebler</surname><given-names>DC</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name></person-group><article-title>Chemoproteomics reveals chemical diversity and dynamics of 4-oxo-2-nonenal modifications in cells</article-title><source>Mol Cell Proteomics</source><year>2017</year><volume>16</volume><fpage>1789</fpage><lpage>1800</lpage><?supplied-pmid 28814509?><pub-id pub-id-type="pmid">28814509</pub-id></element-citation></ref><ref id="CR84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>A</given-names></name><name><surname>Yamada</surname><given-names>R</given-names></name><name><surname>Chang</surname><given-names>X</given-names></name><name><surname>Tokuhiro</surname><given-names>S</given-names></name><name><surname>Sawada</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>M</given-names></name><name><surname>Nagasaki</surname><given-names>M</given-names></name><name><surname>Nakayama-Hamada</surname><given-names>M</given-names></name><name><surname>Kawaida</surname><given-names>R</given-names></name><name><surname>Ono</surname><given-names>M</given-names></name><etal/></person-group><article-title>Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis</article-title><source>Nat Genet</source><year>2002</year><volume>34</volume><fpage>395</fpage><lpage>402</lpage></element-citation></ref><ref id="CR85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Synold</surname><given-names>T</given-names></name><name><surname>Xi</surname><given-names>B</given-names></name><name><surname>Wuenschell</surname><given-names>GE</given-names></name><name><surname>Tamae</surname><given-names>D</given-names></name><name><surname>Figarola</surname><given-names>JL</given-names></name><name><surname>Rahbar</surname><given-names>S</given-names></name><name><surname>Termini</surname><given-names>J</given-names></name></person-group><article-title>Advanced glycation end products of DNA: quantification of N2-(1-Carboxyethyl)-2&#x02019;-deoxyguanosine in biological samples by liquid chromatography electrospray ionization tandem mass spectrometry</article-title><source>Chem Res Toxicol</source><year>2008</year><volume>21</volume><fpage>2148</fpage><lpage>2155</lpage><?supplied-pmid 18808156?><pub-id pub-id-type="pmid">18808156</pub-id></element-citation></ref><ref id="CR86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szende</surname><given-names>B</given-names></name><name><surname>Tyih&#x000e1;k</surname><given-names>E</given-names></name></person-group><article-title>Effect of formaldehyde on cell proliferation and death</article-title><source>Cell Biol Int</source><year>2010</year><volume>34</volume><fpage>1273</fpage><lpage>1282</lpage><?supplied-pmid 21067524?><pub-id pub-id-type="pmid">21067524</pub-id></element-citation></ref><ref id="CR87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szwergold</surname><given-names>BS</given-names></name><name><surname>Howell</surname><given-names>S</given-names></name><name><surname>Beisswenger</surname><given-names>PJ</given-names></name></person-group><article-title>Human fructosamine-3-kinase: purification, sequencing, substrate specificity, and evidence of activity <italic>in vivo</italic></article-title><source>Diabetes</source><year>2001</year><volume>50</volume><fpage>2139</fpage><lpage>2147</lpage><?supplied-pmid 11522682?><pub-id pub-id-type="pmid">11522682</pub-id></element-citation></ref><ref id="CR88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taira</surname><given-names>T</given-names></name><name><surname>Saito</surname><given-names>Y</given-names></name><name><surname>Niki</surname><given-names>T</given-names></name><name><surname>Iguchi-Ariga</surname><given-names>SM</given-names></name><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Ariga</surname><given-names>H</given-names></name></person-group><article-title>DJ-1 has a role in antioxidative stress to prevent cell death</article-title><source>EMBO Rep</source><year>2004</year><volume>5</volume><fpage>213</fpage><lpage>218</lpage><?supplied-pmid 14749723?><pub-id pub-id-type="pmid">14749723</pub-id></element-citation></ref><ref id="CR89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talasz</surname><given-names>H</given-names></name><name><surname>Wasserer</surname><given-names>S</given-names></name><name><surname>Puschendorf</surname><given-names>B</given-names></name></person-group><article-title>Nonenzymatic glycation of histones in vitro and in vivo</article-title><source>J Cell Biochem</source><year>2002</year><volume>85</volume><fpage>24</fpage><lpage>34</lpage><?supplied-pmid 11891847?><pub-id pub-id-type="pmid">11891847</pub-id></element-citation></ref><ref id="CR90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamae</surname><given-names>D</given-names></name><name><surname>Lim</surname><given-names>P</given-names></name><name><surname>Wuenschell</surname><given-names>GE</given-names></name><name><surname>Termini</surname><given-names>J</given-names></name></person-group><article-title>Mutagenesis and repair induced by the DNA advanced glycation end product N2-1-(carboxyethyl)-2&#x02019;-deoxyguanosine in human cells</article-title><source>Biochemistry</source><year>2011</year><volume>50</volume><fpage>2321</fpage><lpage>2329</lpage><?supplied-pmid 21355561?><pub-id pub-id-type="pmid">21355561</pub-id></element-citation></ref><ref id="CR91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teodorowicz</surname><given-names>M</given-names></name><name><surname>Hendriks</surname><given-names>WH</given-names></name><name><surname>Wichers</surname><given-names>HJ</given-names></name><name><surname>Savelkoul</surname><given-names>HFJ</given-names></name></person-group><article-title>Immunomodulation by Processed Animal Feed: the role of maillard reaction products and advanced glycation end-products (AGEs)</article-title><source>Front Immunol</source><year>2018</year><volume>9</volume><fpage>2088</fpage><?supplied-pmid 30271411?><pub-id pub-id-type="pmid">30271411</pub-id></element-citation></ref><ref id="CR92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toyoda</surname><given-names>Y</given-names></name><name><surname>Erkut</surname><given-names>C</given-names></name><name><surname>Pan-Montojo</surname><given-names>F</given-names></name><name><surname>Boland</surname><given-names>S</given-names></name><name><surname>Stewart</surname><given-names>MP</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>DJ</given-names></name><name><surname>Wurst</surname><given-names>W</given-names></name><name><surname>Hyman</surname><given-names>AA</given-names></name><name><surname>Kurzchalia</surname><given-names>TV</given-names></name></person-group><article-title>Products of the Parkinson&#x02019;s disease-related glyoxalase DJ-1, D-lactate and glycolate, support mitochondrial membrane potential and neuronal survival</article-title><source>Biol Open</source><year>2014</year><volume>3</volume><fpage>777</fpage><lpage>784</lpage><?supplied-pmid 25063200?><pub-id pub-id-type="pmid">25063200</pub-id></element-citation></ref><ref id="CR93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trerotola</surname><given-names>M</given-names></name><name><surname>Relli</surname><given-names>V</given-names></name><name><surname>Simeone</surname><given-names>P</given-names></name><name><surname>Alberti</surname><given-names>S</given-names></name></person-group><article-title>Epigenetic inheritance and the missing heritability</article-title><source>Hum Genomics</source><year>2015</year><volume>9</volume><fpage>17</fpage><?supplied-pmid 26216216?><pub-id pub-id-type="pmid">26216216</pub-id></element-citation></ref><ref id="CR94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tzika</surname><given-names>E</given-names></name><name><surname>Dreker</surname><given-names>T</given-names></name><name><surname>Imhof</surname><given-names>A</given-names></name></person-group><article-title>Epigenetics and metabolism in health and disease</article-title><source>Front Genet</source><year>2018</year><volume>9</volume><fpage>361</fpage><?supplied-pmid 30279699?><pub-id pub-id-type="pmid">30279699</pub-id></element-citation></ref><ref id="CR95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Laer</surname><given-names>K</given-names></name><name><surname>Hamilton</surname><given-names>CJ</given-names></name><name><surname>Messens</surname><given-names>J</given-names></name></person-group><article-title>Low-molecular-weight thiols in thiol-disulfide exchange</article-title><source>Antioxid Redox Signal</source><year>2013</year><volume>18</volume><fpage>1642</fpage><lpage>1653</lpage><?supplied-pmid 23075082?><pub-id pub-id-type="pmid">23075082</pub-id></element-citation></ref><ref id="CR96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Schaftingen</surname><given-names>E</given-names></name><name><surname>Delpierre</surname><given-names>G</given-names></name><name><surname>Collard</surname><given-names>F</given-names></name><name><surname>Fortpied</surname><given-names>J</given-names></name><name><surname>Gemayel</surname><given-names>R</given-names></name><name><surname>Wiame</surname><given-names>E</given-names></name><name><surname>Veiga-da-Cunha</surname><given-names>M</given-names></name></person-group><article-title>Fructosamine 3-kinase and other enzymes involved in protein deglycation</article-title><source>Adv Enzyme Regul</source><year>2007</year><volume>47</volume><fpage>261</fpage><lpage>269</lpage><?supplied-pmid 17337043?><pub-id pub-id-type="pmid">17337043</pub-id></element-citation></ref><ref id="CR97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da-Cunha</surname><given-names>Maria&#x000a0;VEIGA</given-names></name><name><surname>Jacquemin</surname><given-names>Patrick</given-names></name><name><surname>Delpierre</surname><given-names>Ghislain</given-names></name><name><surname>Godfraind</surname><given-names>Catherine</given-names></name><name><surname>Th&#x000e9;ate</surname><given-names>Ivan</given-names></name><name><surname>Vertommen</surname><given-names>Didier</given-names></name><name><surname>Clotman</surname><given-names>Fr&#x000e9;d&#x000e9;ric</given-names></name><name><surname>Lemaigre</surname><given-names>Fr&#x000e9;d&#x000e9;ric</given-names></name><name><surname>Devuyst</surname><given-names>Olivier</given-names></name><name><surname>Van&#x000a0;Schaftingen</surname><given-names>Emile</given-names></name></person-group><article-title>Increased protein glycation in fructosamine 3-kinase-deficient mice</article-title><source>Biochemical Journal</source><year>2006</year><volume>399</volume><issue>2</issue><fpage>257</fpage><lpage>264</lpage><pub-id pub-id-type="pmid">16819943</pub-id></element-citation></ref><ref id="CR98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>GR</given-names></name><name><surname>Hirschey</surname><given-names>MD</given-names></name></person-group><article-title>Nonenzymatic protein acylation as a carbon stress regulated by sirtuin deacylases</article-title><source>Mol Cell</source><year>2014</year><volume>54</volume><fpage>5</fpage><lpage>16</lpage><?supplied-pmid 24725594?><pub-id pub-id-type="pmid">24725594</pub-id></element-citation></ref><ref id="CR99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wysocka</surname><given-names>J</given-names></name><name><surname>Sayegh</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>YH</given-names></name><name><surname>Perlin</surname><given-names>JR</given-names></name><name><surname>Leonelli</surname><given-names>L</given-names></name><name><surname>Sonbuchner</surname><given-names>LS</given-names></name><name><surname>McDonald</surname><given-names>CH</given-names></name><name><surname>Cook</surname><given-names>RG</given-names></name><name><surname>Dou</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Human PAD4 regulates histone arginine methylation levels via demethylimination</article-title><source>Science</source><year>2004</year><volume>306</volume><fpage>279</fpage><lpage>283</lpage><?supplied-pmid 15345777?><pub-id pub-id-type="pmid">15345777</pub-id></element-citation></ref><ref id="CR100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wanner</surname><given-names>MJ</given-names></name><name><surname>Zuidinga</surname><given-names>E</given-names></name><name><surname>Tromp</surname><given-names>DS</given-names></name><name><surname>Vil&#x000ed;m</surname><given-names>J</given-names></name><name><surname>J&#x000f8;rgensen</surname><given-names>SI</given-names></name><name><surname>van Maarseveen</surname><given-names>JH</given-names></name></person-group><article-title>Synthetic evidence of the Amadori-type alkylation of biogenic amines by the neurotoxic metabolite dopegal</article-title><source>J Org Chem</source><year>2020</year><volume>85</volume><fpage>1202</fpage><lpage>1207</lpage><?supplied-pmid 31841007?><pub-id pub-id-type="pmid">31841007</pub-id></element-citation></ref><ref id="CR101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>B</given-names></name><name><surname>Berning</surname><given-names>K</given-names></name><name><surname>Quan</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>YT</given-names></name></person-group><article-title>Glycation of antibodies: Modification, methods and potential effects on biological functions</article-title><source>MAbs</source><year>2017</year><volume>9</volume><fpage>586</fpage><lpage>594</lpage><?supplied-pmid 28272973?><pub-id pub-id-type="pmid">28272973</pub-id></element-citation></ref><ref id="CR102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weng</surname><given-names>X</given-names></name><name><surname>Gong</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Yuan</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Hu</surname><given-names>L</given-names></name><etal/></person-group><article-title>Keth-seq for transcriptiome wide RNA structure mapping</article-title><source>Nat Chem Biol</source><year>2020</year><pub-id pub-id-type="doi">10.1038/s41589-019-0459-3</pub-id><?supplied-pmid 32015521?><pub-id pub-id-type="pmid">32015521</pub-id></element-citation></ref><ref id="CR103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>MR</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Villalta</surname><given-names>PW</given-names></name><name><surname>Stornetta</surname><given-names>A</given-names></name><name><surname>Boudreau</surname><given-names>PD</given-names></name><name><surname>Carr&#x000e1;</surname><given-names>A</given-names></name><name><surname>Brennan</surname><given-names>CA</given-names></name><name><surname>Chun</surname><given-names>E</given-names></name><name><surname>Ngo</surname><given-names>L</given-names></name><name><surname>Samson</surname><given-names>LD</given-names></name><etal/></person-group><article-title>The human gut bacterial genotoxin colibactin alkylates DNA</article-title><source>Science</source><year>2019</year><volume>363</volume><fpage>eaar7785</fpage><?supplied-pmid 30765538?><pub-id pub-id-type="pmid">30765538</pub-id></element-citation></ref><ref id="CR104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wuenschell</surname><given-names>GE</given-names></name><name><surname>Tamae</surname><given-names>D</given-names></name><name><surname>Cercillieux</surname><given-names>A</given-names></name><name><surname>Yamanaka</surname><given-names>R</given-names></name><name><surname>Yu</surname><given-names>C</given-names></name><name><surname>Termini</surname><given-names>J</given-names></name></person-group><article-title>Mutagenic potential of DNA glycation: miscoding by (R)- and (S)-N2-(1-carboxyethyl)-2&#x02019;-deoxyguanosine</article-title><source>Biochemistry</source><year>2010</year><volume>49</volume><fpage>1814</fpage><lpage>1821</lpage><?supplied-pmid 20143879?><pub-id pub-id-type="pmid">20143879</pub-id></element-citation></ref><ref id="CR105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name></person-group><article-title>Glyoxalase II, a detoxifying enzyme of glycolysis byproduct methylglyoxal and a target of p63 and p73, is a pro-survival factor of the p53 family</article-title><source>J Biol Chem</source><year>2006</year><volume>281</volume><fpage>26702</fpage><lpage>26713</lpage><?supplied-pmid 16831876?><pub-id pub-id-type="pmid">16831876</pub-id></element-citation></ref><ref id="CR106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>He</surname><given-names>QL</given-names></name><name><surname>Zhao</surname><given-names>ZX</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Kang</surname><given-names>J</given-names></name><name><surname>Tang</surname><given-names>GL</given-names></name></person-group><article-title>Self-resistance to an antitumor antibiotic: a DNA glycosylase triggers the base-excision repair system in yatakemycin biosynthesis</article-title><source>Angew Chem Int Ed Engl</source><year>2012</year><volume>51</volume><fpage>10532</fpage><lpage>10536</lpage><?supplied-pmid 22987648?><pub-id pub-id-type="pmid">22987648</pub-id></element-citation></ref><ref id="CR107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>P</given-names></name></person-group><article-title>Crosstalk of homocysteinylation, methylation and acetylation on histone H3</article-title><source>Analyst</source><year>2015</year><volume>140</volume><fpage>3057</fpage><lpage>3063</lpage><?supplied-pmid 25807213?><pub-id pub-id-type="pmid">25807213</pub-id></element-citation></ref><ref id="CR108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Smith</surname><given-names>BA</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Brock</surname><given-names>A</given-names></name><name><surname>Cho</surname><given-names>C</given-names></name><name><surname>Schultz</surname><given-names>PG</given-names></name></person-group><article-title>A new strategy for the site-specific modification of proteins <italic>in vivo</italic></article-title><source>Biochemistry</source><year>2003</year><volume>42</volume><fpage>6735</fpage><lpage>6746</lpage><?supplied-pmid 12779328?><pub-id pub-id-type="pmid">12779328</pub-id></element-citation></ref><ref id="CR109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>DD</given-names></name><name><surname>Lo</surname><given-names>SC</given-names></name><name><surname>Cross</surname><given-names>JV</given-names></name><name><surname>Templeton</surname><given-names>DJ</given-names></name><name><surname>Hannink</surname><given-names>M</given-names></name></person-group><article-title>Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex</article-title><source>Mol Cell Biol</source><year>2004</year><volume>24</volume><fpage>10941</fpage><lpage>10953</lpage><?supplied-pmid 15572695?><pub-id pub-id-type="pmid">15572695</pub-id></element-citation></ref><ref id="CR110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Bai</surname><given-names>B</given-names></name><name><surname>Mei</surname><given-names>X</given-names></name><name><surname>Wan</surname><given-names>C</given-names></name><name><surname>Cao</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Dan</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Elevated H3K79 homocysteinylation causes abnormal gene expression during neural development and subsequent neural tube defects</article-title><source>Nat Commun</source><year>2018</year><volume>9</volume><fpage>3436</fpage><?supplied-pmid 30143612?><pub-id pub-id-type="pmid">30143612</pub-id></element-citation></ref><ref id="CR111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Tang</surname><given-names>Z</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>G</given-names></name><name><surname>Cui</surname><given-names>C</given-names></name><name><surname>Weng</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Perez-Neut</surname><given-names>M</given-names></name><etal/></person-group><article-title>Metabolic regulation of gene expression by histone lactylation</article-title><source>Nature</source><year>2019</year><volume>574</volume><fpage>575</fpage><lpage>580</lpage><?supplied-pmid 31645732?><pub-id pub-id-type="pmid">31645732</pub-id></element-citation></ref><ref id="CR112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Q</given-names></name><name><surname>Prescott</surname><given-names>NA</given-names></name><name><surname>Maksimovic</surname><given-names>I</given-names></name><name><surname>David</surname><given-names>Y</given-names></name></person-group><article-title>(De)Toxifying the epigenetic code</article-title><source>Chem Res Toxicol</source><year>2019</year><volume>32</volume><fpage>796</fpage><lpage>807</lpage><?supplied-pmid 30839196?><pub-id pub-id-type="pmid">30839196</pub-id></element-citation></ref><ref id="CR113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Q</given-names></name><name><surname>Omans</surname><given-names>ND</given-names></name><name><surname>Leicher</surname><given-names>R</given-names></name><name><surname>Osunsade</surname><given-names>A</given-names></name><name><surname>Agustinus</surname><given-names>AS</given-names></name><name><surname>Finkin-Groner</surname><given-names>E</given-names></name><name><surname>D&#x02019;Ambrosio</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Chandarlapaty</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><etal/></person-group><article-title>Reversible histone glycation is associated with disease-related changes in chromatin architecture</article-title><source>Nat Commun</source><year>2019</year><volume>10</volume><fpage>1289</fpage><?supplied-pmid 30894531?><pub-id pub-id-type="pmid">30894531</pub-id></element-citation></ref><ref id="CR114"><mixed-citation publication-type="other">Zheng Q, Osunsade A, David Y (2019) Protein arginine deiminase 4 antagonizes methylglyoxal-induced histone glycation. bioRxiv doi:10.1101/826818</mixed-citation></ref><ref id="CR115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Q</given-names></name><name><surname>Maksimovic</surname><given-names>I</given-names></name><name><surname>Upad</surname><given-names>A</given-names></name><name><surname>Guber</surname><given-names>D</given-names></name><name><surname>David</surname><given-names>Y</given-names></name></person-group><article-title>Synthesis of an alkynyl methylglyoxal probe to investigate nonenzymatic histone glycation</article-title><source>J Org Chem</source><year>2020</year><volume>85</volume><fpage>1691</fpage><lpage>1697</lpage><?supplied-pmid 31875401?><pub-id pub-id-type="pmid">31875401</pub-id></element-citation></ref><ref id="CR116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Snooks</surname><given-names>H</given-names></name><name><surname>Sang</surname><given-names>S</given-names></name></person-group><article-title>Complexity of advanced glycation end products in foods: Where are we now?</article-title><source>J Agric Food Chem</source><year>2018</year><volume>66</volume><fpage>1325</fpage><lpage>1329</lpage><?supplied-pmid 29378411?><pub-id pub-id-type="pmid">29378411</pub-id></element-citation></ref></ref-list></back></article>